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9Summary
Cohesin is a protein complex, whose core subunits are assembled into a ring-like structure
encircling the DNA. In this manner, cohesin traps DNA molecules and plays key roles in ex-
pression, repair, and segregation of eukaryotic genomes. Esco1 and Esco2 regulate the func-
tion of cohesin by acetylation of Smc3, a subunit of the complex.  Esco1 and Esco2 show dis-
tinct patterns of expression during the cell cycle. Esco1 is present constantly during the cell
cycle; however, Esco2 is highly abundant during the S-phase. Both enzymes have important
implications in human diseases. Mutations of Esco1 have been linked with bladder and endo-
metrial cancer while mutations in Esco2 have been associated to Roberts syndrome (RBS), a
developmental disorder with defective sister chromatid cohesion. Esco1 and Esco2 belong to
the GCN5-related N-acetyltransferases (GNAT) family. While the N-terminal parts of Esco1
and Esco2 are highly divergent and likely account for the functional differences, the C-
terminal GNAT acetyltransferase domains of these enzymes are conserved.
Comprehensive investigation of the catalytic mechanism of the Esco1 and Esco2 acetyltrans-
ferases is essential to understand the role of cohesin acetylation in different cellular functions.
Here, we combined the Mus musculus Esco2 (MmEsco2) structure, in vitro biochemistry, and
cell-based studies to identify the catalytic residues of Esco1 and Esco2 and to gain insights
into the functions of these residues in catalysis.
We determined the structure of the acetyltransferase domain of MmEsco2, natively in com-
plex with coenzyme A (CoA) at 1.8 Å resolution. To characterize the active site of Esco2, a
number of potential catalytic residues were chosen considering their proximity and side chain
orientation toward the CoA in the MmEsco2/CoA complex structure. Next, the functional role
of these potential catalytic residues, S566, D567, E491, and S527 was investigated. For this
purpose, in vitro mutational analysis using incubation of human recombinant cohesin complex
with different variants of full-length human ESCO1 and assessment of SMC3 acetylation was
performed (sufficient amounts of either mouse or human Esco2 could not be purified due to
low expression and solubility). To complement the in vitro assay, in vivo mutational analysis
was performed by transfection of Esco1- and Esco2-deficient mouse embryonic fibroblasts
(MEFs) with different mutants of Esco1 and Esco2. Smc3 acetylation for various mutants of
MmEsco1 and Smc3 acetylation along with sister chromatid cohesion for various mutants of
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MmEsco2 were used as readouts. In vivo results from mutational analysis differed from the in
vitro results. The single mutants were catalytically inactive in the in vitro assays, while the
same mutants exhibited detectable activity in vivo. This inconsistency could be due to the ab-
sence of required cohesin regulatory factors in vitro. Such limitation makes it clear that an in
vivo activity assessment of various Esco1 and Esco2 mutants is crucial in addition to in vitro
analysis.
Taken together, the results from in vitro and in vivo mutational analysis reveal that the four
conserved catalytic residues S566, D567, E491, and S527 in the active site of MmEsco2 and
corresponding residues in MmEsco1 cooperatively play a role in deprotonation of the lysine
substrate. In this proposed mechanism, the general bases, namely aspartate and glutamate,
abstract the proton of substrate lysine via serine residues.
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Introduction
Functions and regulation of cohesin
1.1.1 Cohesin and the cell cycle
The accurate distribution of the genetic material into the two identical daughter cells during
cell division is crucial. Thereby, dividing eukaryote cells go through a series of phases known
collectively as the cell cycle, which is controlled by numerous mechanisms and checkpoints
ensuring accurate cell division (Hartwell and Weinert, 1989). Failure in this process can be
the underlying cause of various human diseases. The cell cycle consists of four distinct phas-
es: G1 (first gap phase), S (synthesis phase), G2 (second gap phase), and mitosis. During G1-
phase, the cell copies organelles, grows physically larger, and makes the various component
that are required for DNA synthesis. Subsequently, the cell enters S-phase and synthesizes a
copy of the DNA. It also duplicates the centrosome which organizes the microtubules and is
essential for DNA separation during mitosis. After completing the S-phase, the cell enters the
G2-phase that is characterized by protein synthesis in preparation for mitosis. At the end of
the G2-phase when the checkpoints are satisfied, the cell progresses into mitosis, including
prophase, metaphase, anaphase and telophase. During prophase, the nuclear membrane breaks
down to a number of small vesicles and the nucleolus fragments. The coiled chromatin begins
to condense into compact chromosomes and the centrosome migrates to opposite poles of the
cell. During this stage, each replicated chromosome consists of two sister chromatids that are
held together by a structure called centromere. In metaphase, the chromosomes align along
the equatorial plate.  As the cell enters into early anaphase, chromatids initiate to separate to
the opposite poles through kinetochore attachment to the spindle microtubules. Once sister
chromatids have separated at the end of anaphase, the final steps of telophase and cytokinesis
yield two identical daughter cells. The accuracy of the chromosome segregation depends on
the fact that replicated chromatids are held together from the time they form in S-phase until
their separation in anaphase. This process, which is known as sister chromatid cohesion, is a
requirement for the bipolar attachment of sister chromatids to the spindle fibers during mito-
sis. Absence of this cohesion could result in early separation of sister chromatids from each
other, before the chromatids attach to both poles of the spindle. Early separation of sister
chromatids in turn could lead to an unequal distribution of sister chromatids to the daughter
cells. Cohesion is present along the sister chromatid arms and at centromeres. However, be-
12
cause of the importance of accurate microtubule attachment to the kinetochores, cohesion is
especially crucial at centromeres.
Two general mechanisms for cohesion have been proposed: First, a persistent catenation of
sister DNA molecules, which physically interlocks (catenates) DNA across the sister chroma-
tids (Murray and Szostak, 1985). Second, a protein connection of DNA molecules via the co-
hesin complex, which physically tether the sister chromatids (Michaelis et al., 1997; Nasmyth,
2009).
In support of the second mechanism, genetic screens of a variety of mutants, defective for
sister chromatid cohesion, in various species identified a number of proteins involved in cohe-
sion (Birkenbihl and Subramani, 1992; Davis, 1971; Guacci et al., 1997; Holt and May, 1996;
Kerrebrock et al., 1992; Michaelis et al., 1997). These proteins were found to be subunits of
the cohesin complex or regulators of this complex and are highly conserved among different
eukaryotes.
The cohesin complex is loaded onto chromatin in G1 (yeast) or telophase (vertebrates) by
Nipbl-Mau2 heterodimer (Scc2-Scc4 in yeast). This process is highly reversible due to pres-
ence of the unloading factors (Wapl-Pds5). During S-phase, acetylation of cohesin by acetyl
transferases Esco1 and Esco2 (Eco1 in yeast) establishes cohesion between two sister chroma-
tids. Cohesin remains chromatin associated through G2-phase. During mitosis, cohesins
which are located between the arms of sister chromatids are released in prophase and the re-
maining cohesins at centromeres are dissociated in anaphase. This allows proper sister chro-
matid resolution and efficient segregation.
1.1.2 Cohesin complex architecture
The cohesin complex is evolutionarily conserved throughout eukaryotes (Table 1) and con-
sists of four core subunits (Anderson et al., 2002; Losada et al., 1998; Peters et al., 2008;
Sumara et al., 2000). Two cohesin core subunits, Smc1 and Smc3, belong to the Smc family
of chromosomal ATPases (ATP-binding cassette [ABC] family) (Figure 1). Smc proteins
have a rod-like shape with a hinge domain on one end and an ATPase head domain at the oth-
er end. A long antiparallel coiled-coil separates the hinge domain from the head domain. In-
teraction of Hinge domains Smc1 and Smc3 leads to the formation of a Smc heterodimer. The
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third main cohesin subunit, Rad21 (Scc1 in yeast), belongs to the kleisin protein family. The
C-terminal of the Rad21 subunit binds to the Smc1 head domain and the N-terminal of this
subunit binds to the Smc3 head domain. In this way, Rad21 creates a triple ring. The forth
subunit, SA1 or SA2 (Scc3 in yeast), binds to the middle region of Rad21 (Gligoris et al.,
2014; Haering et al., 2008; Haering et al., 2002; Hara et al., 2014; Hirano and Hirano, 2002;
Melby et al., 1998). The ring-like structure of the cohesin complex with a diameter of ~50 nm
has been shown by electron microscopic images of this complex, either puriﬁed from cell ex-
tracts or reconstituted using recombinant proteins (Anderson et al., 2002; in 't Veld et al.,
2014). This ring is big enough to topologically trap the two sister chromatids and thereby
keep them together (Haering et al., 2008; Haering et al., 2002; Ivanov and Nasmyth, 2005;
Murayama and Uhlmann, 2014).
Figure 1: Architecture of the cohesin complex.
In vertebrates, the cohesin core complex consists of Smc1, Smc3, Rad21, and either SA1 or SA2. The
names of the orthologs in yeast are shown in parentheses. Smc proteins fold back on themselves with the
hinge domain at one end and the ATPase domain at the other end. Smc1 and Smc3 hinges interact directly
together while their head domains connect via the kleisin subunit Rad21. The SA subunit associates with
the middle region of the Rad21. Known interaction sites for cohesin regulators Pds5, Nipbl, and Wapl are
shown. Nipbl and Pds5 bind the same part on Rad21 (darkertone). The illustration is modified from
Morales and Losada (2018).
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1.1.3 Cohesin functions
As noted above, there are several lines of evidence that the cohesin ring traps the two sister
chromatids and functions as molecular glue ensuring equal segregation of sister chromatids
during mitosis (Ciosk et al., 2000; Losada et al., 1998; Tanaka et al., 2000) and meiosis (Klein
et al., 1999).
Beyond cohesion, different reports have shown that cohesin mutants are defective in DNA
damage repair. Following DNA damage, cohesin normally accumulates on the DNA double-
strand breaks (DSB) sites and allows postreplicative homologous recombination repair of
DNA DSBs (Kim et al., 2002; Sjogren and Nasmyth, 2001).
In addition, cohesin has been shown to be important for CTCF-dependent gene regulation,
which is known to be mediated by chromatin looping. Since cohesin is able to physically con-
nect DNA strands, it has been proposed that it could form or stabilize chromatin loops (Wendt
and Peters, 2009; Wendt et al., 2008). This hypothesis has been supported by chromatin con-
Table 1: Cohesin subunits and regulatory protein homologs.
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formation capture (3C) experiments which revealed that long-range chromosomal interactions
are cohesin dependent (Hadjur et al., 2009; Kagey et al., 2010; Nativio et al., 2009).
1.1.4 Cohesin loading and unloading
Cohesin rings, via entrapping DNA, regulate chromosome segregation, transcription, and
DNA repair. All these functions are dependent on the proper regulation of cohesin association
and disassociation on chromatin (Haarhuis et al., 2014a).
The cohesin ring has two outer gates: (1) the interface between the head domain of Smc3 and
the N-terminal of Rad21 (exit gate) and (2) the interface between the hinge domains of Smc1
and Smc3 (entry gate) (Figure 2) (Gruber et al., 2006; Haarhuis et al., 2014b; in 't Veld et al.,
2014). In addition, cohesin has a third ‘inner gate’ between the head domains of Smc1 and
Smc3, which is regulated by binding and hydrolysis of ATP (Figure 2). Binding of two ATP
molecules to the head domains of Smc1 and Smc3 closes the inner gate. Hydrolysis of these
ATP molecules on the other hand drives the head domains apart and opens this gate
(Beckouet et al., 2016; Murayama and Uhlmann, 2015).
Cohesin is loaded onto chromatin as vertebrate cells enter G1-phase by a mechanism that de-
pends on the heterodimer Nipbl-Mau2 (Scc2-Scc4 in budding yeast), whereas it is released
from the chromatin by the Wapl and Pds5 regulators (Chao et al., 2017a; Ciosk et al., 2000;
Tedeschi et al., 2013; Weitzer et al., 2003).
It is believed that the heterodimer, Nipbl-Mau2, promotes loading of cohesin onto chromatin
by stimulating ATP hydrolysis of the Smc heads (Chao et al., 2015; Chao et al., 2017a;
Weitzer et al., 2003). However, in the absence of this cohesin loader in vitro, cohesin can still
bind topologically to DNA to some extent (Murayama and Uhlmann, 2014). It has been pro-
posed that cohesin entraps DNA through an entry gate between the Smc1 and Smc3 hinge
domains (Figure 2) (Gruber et al., 2006). The coiled-coils of Smc might transmit conforma-
tional changes induced by ATP hydrolysis from the head to the hinge domains and promote
entry gate opening (Nasmyth, 2011). The heterodimer Nipbl-Mau2 interacts with SA1/2.
Hence, SA1/2 subunit connects the cohesin loader to the Smc head domains and increases
both the ATPase activity of cohesin and its loading onto chromatin. However, the SA1/2 still
stimulates the cohesin loading and ATPase activity in the absence of cohesin loader to some
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extent. This suggests that SA1/2 also affects the loading process independent of Nipbl-Mau2
(Murayama and Uhlmann, 2014).
It has been proposed that after cohesin loading onto DNA, ATP rebinding closes the inner
gate of cohesin and locks DNA between the Smc1 and Smc3 coiled-coils. The entrapped
DNA in turn stimulates ATPase activity of Smc3 head domain, likely by direct interaction
with a basic patch on this domain, harboring the two conserved lysines, K105 and K106
(Camdere et al., 2015; Murayama and Uhlmann, 2015; Yu, 2016). Subsequently, ATP hy-
drolysis and nucleotide release result in dissociation of the Smc3 and Smc1 head domains and
allow passage of the DNA to the inner gate (Beckouet et al., 2016; Camdere et al., 2015;
Elbatsh et al., 2016). Next, new ATP molecules bind the Smc head domains and close the
inner gate. After this step, Wapl-Pds5 dissociates the Smc3-Rad21 dimer and hence, DNA is
released from the cohesin ring through the exit gate (Ouyang and Yu, 2017).
In vivo analyses the of cohesin binding pattern to chromosomes have shown that the main
population of cohesin complexes are loaded around centromeres, in addition to gene promo-
tors along chromosome arms (D'Ambrosio et al., 2008; Ocampo-Hafalla et al., 2007). In
mammalian cells, many of the cohesin binding sites overlap with the CTCF and are different
from their loading sites. Translocation of cohesin from promoters to CTCF-binding sites is
not well understood (Parelho et al., 2008; Uhlmann, 2016; Wendt et al., 2008). Recent studies
suggest that loop extrusion could play an important role in this process (Barrington et al.,
2017).
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1.1.5 Cohesion establishment
In S-phase, cohesion can be established once DNA has been replicated in a process that de-
pends on the acetylation of the two conserved lysine residues (K105 and K106) on the basic
patch of the Smc3 head domain. It has been proposed that acetylation of these two lysine resi-
dues neutralize the positive charge of the basic patch, thereby weakening the DNA binding
and reducing ATPase activity. This stops the release of DNA through the cohesin exit gate,
counteracts Wapl and Pds5 functions and leads to stable DNA entrapment inside the cohesin
ring (Ben-Shahar et al., 2008; Murayama and Uhlmann, 2015; Unal et al., 2008; Yu, 2016). In
Figure 2: Cohesin loading and unloading onto chromatin during the cell cycle in vertebrate cells.
Left: in G1-phase, the Nipbl-Mau2 dimer is loading cohesin onto chromatin by stimulating the ATP hydrolysis
of the Smc head domains. The entry gate is located between the hinge domains of the Smc1 and Smc3 proteins
(a). The inner gate resides between the two Smc head domains. This gate closes and opens by ATP binding and
hydrolysis, respectively (b). The unloading process depends on Wapl and Pds5. DNA is released via an exit
gate located between the Smc3 head domain and Rad21 (c). During DNA replication in S-phase (middle),
cohesion establishment occurs via Smc3 acetylation by Esco1 and Esco2. Subsequently, acetylated cohesin
recruits Sororin, which antagonizes Wapl and mediates sister chromatid cohesion. Right: Dissociation of cohe-
sin during mitosis proceeds in two steps. The majority of cohesin is released from the chromosome arms dur-
ing prophase by Wapl. In this phase, cohesin and Sororin become phosphorylated by Cdk1 and Aurora B ki-
nases. At centromeres, cohesin is protected from dissociation by the Sgo1–PP2A complex, which dephosphor-
ylates cohesin and Sororin in this region. In addition, Sgo1 and Haspin compete with binding of Wapl to cohe-
sin and Pds5, respectively. Finally, during anaphase, centromeric cohesin is released by Separase-mediated
cleavage of Rad21 that allows the accurate separation of the sister chromatids. The illustration is adapted from
Morales and Losada (2018).
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vertebrates, cohesion establishment involves an additional component, Sororin, which com-
petes with Wapl for binding to Pds5 and in this way antagonizes the Wapl-Pds5 releasing ac-
tivity (Carretero et al., 2013; Nishiyama et al., 2010). Smc3 acetylation is essential for Sororin
recruitment to cohesin.
How cohesin holds two sister chromatids together is not well understood. Protein crosslinking
experiments have provided evidence for a “one ring model”, in which one cohesin ring en-
traps both sister chromatids. Alternatively, a “handcuff model” has been proposed. This mod-
el suggests that each of two sister chromatids is entrapped by one cohesin ring, which inter-
connect to each other. A few other models have also been proposed, including fusion of the
two cohesin rings to make a larger ring that embraces sister chromatids (Haering et al., 2008;
Zhang et al., 2008; Zhang and Pati, 2015). To achieve embracing of both sister chromatids by
one cohesin ring (one ring model) one possibility could be that the replisome passes through
DNA-bound cohesin rings. Because of the size restrictions, presumably the replisome cannot
simply pass through the cohesin ring (Stigler et al., 2016). Instead, cohesin could capture both
sister chromatids in the vicinity of the replication fork (Lengronne et al., 2006). This possibil-
ity, may link cohesin de novo loading and cohesin acetylation and therefore explain the re-
quirement of cohesin's ATPase activity for Smc3 acetylation (Ladurner et al., 2014).
Acetylation of the two conserved lysine residues in the Smc3 head domain is mediated by the
cohesin acetyltransferases Esco1 and Esco2 (Eco1 in yeast). Esco1 and Esco2 both consist of
a divergent N-terminus, a C2H2 zinc finger and a conserved C-terminus acetyltransferase
domain (Hou and Zou, 2005). The relative contributions of these paralogs to cohesin regula-
tion are not entirely clear. Several studies have suggested that both Esco1 and Esco2 are en-
gaged in sister chromatid cohesion, as depletion of both enzymes in cells results in sister
chromatid cohesion defects which are more severe than either single depletion (Hou and Zou,
2005; Kawasumi et al., 2017; Minamino et al., 2015). In contrast, some evidence suggests that
Esco2 is mainly responsible for the establishment of cohesion, possibly via recruitment of
Sororin to cohesin and stabilizing cohesin around sister chromatids during S-phase. In con-
trast, Esco1 may contribute to gene regulation likely by stabilizing cohesin around single
chromatids during interphase (chromatin looping) (Rahman et al., 2015). Esco1 and Esco2
show distinct patterns of expression during the cell cycle. Esco1 is constantly present
throughout the cell cycle, while Esco2 is highly abundant during the S-phase. Esco2 is a sub-
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strate of the anaphase promoting complex/cyclosome (APC/C), an E3 ubiquitin ligase that is
activated at mitotic exit (Lafont et al., 2010; Song et al., 2012). Thus, Esco2 levels are low in
mitosis and G1-phase, and only increase as APC activity reduces during S-phase. It has been
shown that Esco1 directly interacts with cohesin via Pds5. Such a direct interaction with cohe-
sin has not been observed for Esco2 (Minamino et al., 2015). Instead, Esco2 interacts with the
replication proteins, proliferating cell nuclear antigen (PCNA) (Higashi et al., 2012; Song et
al., 2012) and minichromosome maintenance protein complex (MCM) (Ivanov et al., 2018;
Minamino et al., 2018).
Similar to cohesin and its regulatory subunits, Esco1 and Esco2 also are associated with hu-
man developmental disorders (Krantz, 2014; Liu and Krantz, 2008). Mutations in or overex-
pression of Esco1 have been associated with endometrial and bladder cancer, respectively
(Price et al., 2014; Zhang et al., 2016). Mutations in Esco2 have been associated with Roberts
syndrome (RBS), a childhood autosomal recessive disorder (Gordillo et al., 1993; Gordillo et
al., 2008; Vega et al., 2005). RBS patients are characterized by various degree of mental re-
tardation and a number of dysmorphologies. Most of Esco2 mutations involve premature stop
codons in the N-terminal part of the enzyme. These mutations lead to the expression of a trun-
cated Esco2 protein with no enzymatic activity (Gordillo et al., 2008). Metaphase chromo-
somes from RBS patient show a loss of cohesion in the pericentric heterochromatin (PCH)
while cohesion is maintained on the arms (Van Den Berg and Francke, 1993). These chromo-
somes show a parallel alignment of sister chromatids that in combination with repulsion in
PCH, results in a ‘railroad track’ appearance of chromosomes (Maserati et al., 1991). These
findings indicate that Esco2 function must be compensated by Esco1 to some extent at least in
human cells, since its deficiency is compatible with life (Vega et al., 2005). By contrast, Es-
co2-deficient mouse embryos die early in development (Whelan et al., 2012). Similar to hu-
man RBS patient cells, Esco2-deficient mouse embryonic fibroblasts (MEFs) show severe
centromeric cohesion defects while cohesion is sustained along the arms. Therefore, Esco2
could play the key role in the establishment of cohesion around centromeres while Esco1
might be involved in cohesion along arms in the absence of Esco2 (Whelan et al., 2012).
1.1.6 The prophase pathway of cohesin dissociation
In most eukaryotic cells, cohesin dissociation takes place during two phases of mitosis
(Losada et al., 1998; Peters et al., 2008; Sumara et al., 2000; Waizenegger et al., 2000). The
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first dissociation takes place during prophase and prometaphase, when most of the cohesin
dissociates from the chromosome arms. The second phase occurs at the onset of anaphase,
when the residual cohesin on chromosomes, mostly at centromeres, dissociates because of
cleavage of the Rad21 subunit by Separase (Hauf et al., 2001; Kumada et al., 2006; Nakajima
et al., 2007; Uhlmann et al., 1999; Uhlmann et al., 2000; Wirth et al., 2006). Several proteins
and events are required for the prophase pathway of cohesin unloading. A number of studies
indicate that polo-like kinase 1 (Plk1) contributes to cohesin dissociation by phosphorylation
of the SA subunit (Hauf et al., 2005; Morales and Losada, 2018). Other mitotic kinases, e.g.
Aurora B and cyclin-dependent kinase 1 (Cdk1), are also required for efficient dissociation of
cohesin from chromosomes in prophase (Gimenez-Abian et al., 2004; Losada et al., 2002).
These kinases phosphorylate Sororin, which results in the dissociation of this protein from
Pds5. Subsequently, Wapl replaces Sororin, binds to Pds5 and opens the cohesin ring
(Nishiyama et al., 2013). Together, these mitotic phosphorylation events are thought to acti-
vate the cohesin unloading process in prophase. Cohesin at the centromere is protected from
this activity by dephosphorylation. The protein Shugoshin (Sgo1) is targeted to the centro-
mere by Aurora B and budding uninhibited by benzimidazoles 1 (Bub1) kinase, recruiting the
protein phosphatase 2A (PP2A) (Huang et al., 2007; Kitajima et al., 2004; Kitajima et al.,
2006; Riedel et al., 2006). This causes localized dephosphorylation of both cohesin and Soror-
in, thus inhibiting cohesin unloading at the centromere (Liu et al., 2013; McGuinness et al.,
2005). Another mitotic kinase, Haspin, is also recruited to centromere and outcompetes Wapl
binding to Pds5. Haspin and Bub1 phosphorylate histones H3 and H2A, respectively, result-
ing in the recruitment of the chromosomal passenger complex (CPC), which is essential for
centromeric cohesion (Hengeveld et al., 2017).
At the end of metaphase, when cells have bioriented all of their chromosomes on the mitotic
spindle, the spindle checkpoint signaling is stopped and the Anaphase-promoting com-
plex/cyclosome (APC/C) becomes active. This results in ubiquitylation and subsequent deg-
radation of several APC/C substrates, including the Separase inhibitors: Securin and the acti-
vating subunit of Cyclin-dependent kinase 1 (Cdk1). These reactions lead to activation of
separase (Peters, 2002). Before APC/C is active, Separase is inhibited in interphase and early
mitosis by interaction with Securin (Hornig et al., 2002; Waizenegger et al., 2002). Separase
in vertebrates is additionally inhibited by Cdk1-mediated phosphorylation and by interaction
with Cdk1’s cyclin B subunit (Gorr et al., 2005; Huang et al., 2008; Huang et al., 2005;
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Stemmann et al., 2001). In vertebrate cells, APC/C activation thus releases Separase from two
inhibitory mechanisms via ubiquitylation of Securin and cyclin B. As soon as Separase turns
into its active state it cleaves the Rad21 subunit, which results in opening of the cohesin ring,
dissociation of cohesin from chromosomes and separation of sister chromatids (Uhlmann et
al., 1999; Uhlmann et al., 2000).
Smc3 acetylation by Esco1 and Esco2
1.2.1 Esco1 and Esco2 belong to GCN5 family
Acetylation reactions, catalyzed by several groups of enzymes, play a key role in various bio-
logical processes including intracellular localization, enzyme activity, protein-protein interac-
tions, protein stability and transcriptional regulation. The best characterized acetyltransferase
enzymes are histone acetyltransferases (HATs), which catalyze histone acetylation and play a
role in many epigenetic processes (Eberharter and Becker, 2002; Yang and Seto, 2007). HATs
are classified into different subfamilies including Histone acetyltransferase 1 (HAT1),
Gcn5/PCAF, MYST, CBP/p300, and Rtt109, based on sequence and substrate acetylation
profiles. All HATs share a structurally similar acetyl coenzyme A (AcCoA) binding site
(Tanner et al., 2000a; Tanner et al., 2000b; Wang et al., 2008). It has been shown that some of
the HATs, such as members of the CBP/p300 and MYST families, also acetylate non-histone
proteins. Esco1 and Esco2 belong to the GCN5-related N-acetyltransferase (GNAT) family.
Despite the highly divergent N-terminal parts of Esco1 and Esco2, which presumably are the
cause of their functional differences, the C-terminal GNAT acetyltransferase domains of these
two enzymes are considerably conserved (Hou and Zou, 2005; Ivanov et al., 2002; Neuwald
and Landsman, 1997; Roth et al., 2001). Esco1 and Esco2 contain a zinc-finger (ZnF) domain
that is similar to those found in other HAT family members. The ZnF typically mediates both
DNA binding and protein interactions in HATs (Akhtar and Becker, 2001; Koehler et al.,
2014; Toleman et al., 2006). However, it has also been shown that the ZnF is important for
acetyltransferase activity in Esco1 and Esco2 (Onn et al., 2009).
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1.2.2  GNAT family structure, acetyl-CoA binding and substrate recognition
Members of the GNAT superfamily have been identified in various organisms. These en-
zymes catalyze the transfer of an acetyl group from AcCoA to the primary amine moiety of a
wide range of substrates such as glucosamine 6-phosphate, aminoglycoside antibiotics, sper-
midine, spermine, dopamine, histones and non-histone proteins (Dyda et al., 2000; Majorek et
al., 2013; Vetting et al., 2005). Protein acetyltransferases from Sulfolobus solfataricus
(SsPAT) (Brent et al., 2009), human α-tubulin acetyltransferase 1 (αTAT1) (Friedmann et al.,
2012), human Naa50p (Liszczak et al., 2011) and M. tuberculosis AcCoA synthetase N-
acetyltransferase (Rv0998) (Lee et al., 2012) are representative members of this family that
acetylate histone and non-histone proteins (Salah Ud-Din et al., 2016). All of these enzymes
acetylate the amino group of a lysine in the protein substrate, except for Naa50p, which trans-
fers the acetyl group to the α-amino group of N-terminal methionine in protein substrates. The
structures of these enzymes have been determined: They consist of a β-sheet-helix core region
which is structurally conserved among all HATs (colored blue in Figure 3), irrespective of the
sequence conservation (Salah Ud-Din et al., 2016). This core region is flanked by variable N-
and C-terminal structural motifs (colored green in Figure 3), which are likely responsible for
substrate recognition. The AcCoA cofactor is wedged in a groove between structurally con-
served α-helices (Figure 3). Residues that contribute to the protein-AcCoA interaction are
typically not conserved. Similar to other HATs, these acetyltransferases use CoA both as an
acetyl donor in enzymatic reactions and as a molecule to stabilize the overall folding of the
acetyltransferase domain (Friedmann and Marmorstein, 2013; Trievel et al., 1999; Yuan et al.,
2012).
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1.2.3 GNAT family catalysis mechanism
AcCoA dependent acetyltransferases utilize one of two catalytic mechanisms, the ping-pong
or the sequential mechanism (Figure 4). The Ping-pong mechanism involves the formation of
an acetylated enzyme intermediate after binding and reaction with AcCoA (Figure 4, upper
panel). The product (CoASH) is released; protein substrate binds, and the ϵ-amino group of
lysine reacts with the intermediate to generate the final acetylated protein product. In a se-
quential mechanism (Figure 4, lower panel), both AcCoA and the substrate bind to the en-
zyme and form a ternary complex allowing the lysine to directly attack the bound AcCoA,
without the formation of a covalent enzyme intermediate.
Figure 3. Structure of non-histone acetyltransferases.
Ribbon representation of acetyltransferase domains of (A) Tetrahymena GCN5 (TtGcn5), (B) αTAT1, (C),
Naa50p, (D) Rv0998, and (E) SsPAT. The conserved acetyltransferase core region is colored blue, and the
variable flanking fragments are colored green. AcCoA and CoA are shown as stick and colored according
to element: carbon, yellow; nitrogen, blue; oxygen, red. Figure adapted from Friedmann and Marmorstein
(2013).
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Several lines of evidence show that the GNAT family uses a sequential mechanism (Tanner et
al., 2000a; Tanner et al., 2000b; Tanner et al., 1999; Yan et al., 2002), using a conserved glu-
tamate residue as a general base (:B in Figure 4) (Clements et al., 1999; Trievel et al., 1999).
Gcn5 is one of the GNAT enzymes that uses a glutamate as a general base for catalysis and
has a very efficient turnover number (kcat = 210 min−1) (Poux et al., 2002). Structural and ki-
netic analyses have shown that Rv0998 uses Glu235, which is positioned in similar way as the
glutamate of Gcn5 (Lee et al., 2012). Interestingly, some of the Gcn5 family members do not
use this particular glutamate for deprotonation as is the case in SsPAT, Naa50p and αTAT1.
SsPAT has a glutamate residue (E76) at the equivalent position in its structure, but SsPAT
does not solely use this residue as a general base for deprotonation. Instead, this enzyme relies
on a number of additional residues (Y38, E42, E43, D53, H72, E76) which function as a “pro-
ton wire” to deprotonate the substrate lysine (Brent et al., 2009). The rate of reaction by
SsPAT (kcat = 2 min−1) is much slower than that of Gcn5. In addition, studies on Naa50p sug-
Figure 4: Catalytic mechanisms for acetyltransferase enzymes.
The reaction at the top shows the ping-pong catalytic mechanism in which an acetyl-enzyme intermediate
is formed. The reaction at the bottom shows the sequential catalytic mechanism. In this mechanism,
both AcCoA and protein bind to the enzyme forming a ternary complex, prior to any chemical step. The
figure was adapted from Berndsen and Denu (2005).
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gest that catalysis by this enzyme does not rely on one particular residue. Naa50p utilize a
tyrosine and histidine (Y73 and H112) to deprotonate the amino group of the substrate via a
water molecule (Liszczak et al., 2011). This reaction appears to occur at kcat = 7 min−1. Differ-
ent reports have proposed an acetyl transfer mechanism involving several catalytic residues
also for αTAT1 that uses D157, C120 and Q58 as general bases (Friedmann et al., 2012;
Taschner et al., 2012). Kinetic experiments revealed that αTAT1 has a very inefficient catalyt-
ic rate (kcat = 12 min−1) (Friedmann et al., 2012; Taschner et al., 2012). In addition to these
non-histone protein acetyltransferase enzymes, some of the GNAT members, which acetylate
small molecules, have been shown to use more than one catalytic residue. Dopamine N-
acetyltransferase from D. melanogaster (Dat) is an example for a group of enzymes which
catalyze the acetylation reaction using E47 and S182 (Cheng et al., 2012).
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Aims of the study
In mammals, Esco1 and Esco2 acetylate Smc3, which subsequently counteracts Wapl and
Pds5 function and thereby stabilizes cohesin on chromatin. In this way, Esco1 and Esco2 are
engaged in various cellular functions of cohesin, such as sister chromatid cohesion, regulation
of gene expression and DNA repair. Esco1 and Esco2 belong to the GNAT family of histone
acetyltransferases. The C-terminal acetyltransferase domains of these paralogs show a high
degree of homology with 60% sequence identity (Hou and Zou, 2005; Ivanov et al., 2002;
Neuwald and Landsman, 1997).
Thorough investigation of the catalytic mechanism of the acetyltransferases Esco1 and Esco2
is essential to understand the role of cohesin acetylation in different cellular functions. Before
we started to work on this project, no structural and comprehensive functional study of these
enzymes was available. Thus, the main goal of this thesis was to combine the Esco1 or/and
Esco2 structures, in vitro biochemistry and cell-based studies in order to identify the catalytic
residues of these enzymes and to gain insights into their functions in catalysis. In the course of
completing this thesis, three studies were published about structures, along with limited bio-
chemical characterization of Homo sapiens ESCO1 (HsESCO1) and its ortholog in Xenopus
Eco2 (xEco2) (Chao et al., 2017b; Kouznetsova et al., 2016; Rivera-Colon et al., 2016). One
study proposed a substrate-assisted catalytic mechanism for HsESCO1 (Kouznetsova et al.,
2016). The authors argued that HsESCO1 lacks a carboxylic acid side chain within the active
site that might function as a general base. The authors propose that HsESCO1 uses an aspar-
tate (D107) of the substrate Smc3 for deprotonation of the neighboring lysine residues K105
and K106. However, Smc3 D107 is located on the opposite side of the ϵ-amino group of the
targeted lysines in the xEco2/Smc3 peptide complex structure and interacts with two con-
served residues of xEco2. This implies that D107 plays a role in enzyme binding rather than
catalysis (Chao et al., 2017). Another group combined a structure-guided study of HsESCO1
with site-directed mutagenesis. They studied a number of potential catalytic residues using in
vitro acetylation assay with a Smc3 peptide as substrate and reported that D810 in HsESCO1
could play a role as a general base (Rivera-Colon et al., 2016). However, this residue is not
conserved in ScEco1 (Figure 7), which suggests that in yeast some other residues carry out
substrate lysine deprotonation.
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In our study, we aimed to overcome the limitations of the previous studies by using in vivo
and in vitro assays of Esco1/2 catalysis along with structure that we determined independent-
ly. To achieve this goal we did the following:
1) Determine the structure of the murine Esco2 acetyltransferases because our experimental,
cell-based analysis are conducted with the murine model.
2) From the structure, determine the architecture of the active site and compare this structure
with other acetyltransferases and with published Esco structures from other organisms. This
includes identification of the general bases that capable of abstracting the proton from the ϵ-
amino group of Smc3 substrate lysines.
3) In vitro Smc3 acetylation using recombinant wild type and mutants Esco1 or/and Esco2
protein. These in vitro studies are based on use of the entire cohesin ring as substrate.
4) In vivo Smc3 acetylation experiments with wild type murine Esco1 and with a series of
single and double mutants of residues that may be involved in catalysis.
5) In vivo Smc3 acetylation along with complementation assays, sister chromatid cohesion
and Aurora B localization, with wild type and mutants MmEsco2.
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Material and Methods
Antibodies
Rabbit antibody against MmEsco1 was generated in the laboratory of Gregor Eichele using a
haemocyanin-conjugated peptide comprising amino acids 521 to 606 of mouse Esco1
(1:1000). The following previously described custom-made antibodies were used: anti-Esco2
(Whelan et al., 2012) (1:1000), mouse anti-acetyl-Smc3 (a gift from K. Shirahige) (Nishiyama
et al., 2010) (1:1000). The following commercial antibodies were used: rabbit anti-Smc3 (Cell
Signaling D47B5, 1:3000), conjugated mouse anti-TBP (Abcam 197874, 1:5000), conjugated
mouse anti-His tag (Novus 31055H, 1:1000), anti-Aurora B (Sigma-Aldrich A5102, 1:100,
for immunofluorescence).
Protein expression in insect cells
2.2.1 Cloning and mutagenesis
Truncated mouse Esco2368-592 with a C-terminal His-tag was cloned into the pFL vector. Full-
length HsEsco1 and HsEsco2 were cloned into the pFastbac-HTC vector (Invitrogen) with an
N-terminal His-tag. Standard restriction-ligation methods were used to introduce these
cDNAs into the plasmids. Briefly, cDNAs were amplified using PCR and purified using etha-
nol precipitation. Vectors and purified PCR products were digested for 4 h at 37 °C using
restriction endonucleases (New England Biolabs, NEB). Digestion of the MmEsco2368-592
PCR product and pFL vector were performed using EcoRI/HindIII restriction enzymes, diges-
tion of HsEsco1 and HsEsco2 PCR products and pFastbac-HTC vector were done using
BamHI/HindIII and SalI/BamHI, respectively. Digested vectors were subsequently
dephosphorylated by addition of antarctic phosphatase (NEB). DNA fragments were separat-
ed by agarose gel electrophoresis (0.7% w/v agarose) and extracted using the QIAquick gel
extraction kit (Qiagen). PCR product and linearized vector (1:5 molar ratio of insert to vector)
were ligated overnight at 16 °C using T4 DNA ligase (NEB). After ligation, DNA was trans-
formed into DH10B Cells (NEB) using electroporation. Afterwards, cells were plated on Lys-
ogeny broth (LB) agar plates containing the corresponding antibiotics for selection of trans-
formed cells and incubated overnight at 37 °C. A single colony was used to inoculate 4 ml of
Lysogeny broth medium (LB-medium) containing the corresponding antibiotic. The culture
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was grown overnight at 37 °C and plasmids were isolated using the spin miniprep kit (Qi-
agen).
HsScc1 was cloned into a 438-C vector, containing an N-terminal His-tag followed by a malt-
ose binding protein (MBP) tag and a tobacco etch virus (TEV) protease cleavage site. Cloning
into this vector was performed using ligation independent cloning (LIC) method (Figure 5).
The principle of LIC cloning is that linear DNA fragments can be assembled into a defined
chimeric plasmid by making DNA ends single stranded and  complementary to one another.
Complementary DNA ends are achieved by the addition of nucleotide tags to the 5’ ends of
the oligos used to PCR the targets.  Complementary DNA ends are then made single stranded
using an exonuclease.  Annealing of the DNAs results in a nicked-chimeric plasmid that is
then transformed directly into E. coli. Based on this method, HsScc1 was amplified by PCR
using primers carrying tags at their 5' end:
Forward tag:
5´TAC TTC CAA TCC AAT GCA xxxxxxxxxxxxxx3´
         Y          F        Q         S        N          A        target PCR oligo
Reverse tag:
5´TTATCCACTTCCAAT G TTA TTA xxxxxxxxxxxxxxxx3´
Stop   Stop           target PCR oligo
The PCR product was purified using ethanol precipitation. The 438-C vector was linearized
with SspI restriction enzyme. PCR product and linearized vector were run on an agarose gel
and extracted. Purified vector and PCR product were treated with T4 DNA polymerase in the
presence of dGTP and dCTP, respectively. The protocol is described below:
10 μl gel purified vector or PCR product (50-150 ng), 2 μl dCTP or dGTP (25 mM stock), 2
μl T4 DNA pol 10x Buffer, 1 μl 100 mM DTT, 0.4 μl EMD/Novagen T4 DNA pol and 4.6 μl
H2O.
The reactions were incubated in a thermocycler at 22 °C for 30 min followed by 75 °C for 20
minutes. To anneal, 2 μl LICed PCR and 2 μl LICed vector were incubated in 10 μl of total
volume for 10 min at RT. The annealed DNAs were transformed into DH10B cells (NEB)
using electroporation. Isolation of plasmids was done as described above for other plasmids.
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HsSmc3-FLAG and HsSmc1-His in pFastbac vector were provided by peters lab (Ladurner et
al., 2014). To produce tetramer complex, combined Smc1, Smc3-FLAG, Scc1 and His-SA1 in
a pFL multibac vector was also provided by peters lab (Ladurner et al., 2014).
2.2.1 Baculovirus generation
 The recombinant plasmids were transformed into DH10BAC competent cells, which contain
a modified viral bacmid Bmon14272 (Invitrogen) and a helper plasmid (Pmon7124), using
electroporation. The bacmid has a yellow fluorescent protein (YFP) expression cassette to
monitor protein expression and a mini-attTn7 target site and lacZα gene. The helper plasmid
is tetracycline resistant and encodes a transposase for Tn7 transposition. The mini-Tn7 ele-
ment on the recombinant plasmid can transpose to the mini-attTn7 target site on the bacmid in
the presence of transposase provided by the helper plasmid. Colonies containing recombinant
bacmids were identified by antibiotic selection (100 µg ml-1 ampicillin, 10 µg ml-1 tetracy-
cline, 50 µg ml-1 kanamycin, 7 µg ml-1 gentamicin) and blue/white screening (X-gal and in-
ducer Isopropyl β-D-1-thiogalactopyranoside [IPTG]). White clones were chosen as positive
for transposition, since the transposition results in disruption of the LacZα gene and prevents
colonies from turning blue in the presence of X-gal along IPTG. Positive clones were inocu-
lated in LB containing the corresponding antibiotic and incubated at 37 °C overnight. Recom-
Figure 5: Sschematic illustration of the ligation independent cloning (LIC) method used for cloning.
HsSmc3-FLAG, HsSmc1-His in pFastbac and combined Smc1, Smc3-FLAG, Scc1 and His-SA1 in a pFL
multibac vector were provided by Jan-Michael Peters lab (Research Institute of Molecular Pathology, Vi-
enna). Point mutations in HsEsco1 were introduced with the QuikChange II XL site-directed mutagenesis
kit (Agilent Technologies) according to the manufacturer’s manual and were verified by DNA sequencing.
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binant bacmid was isolated with a partially modified protocol using the miniprep kit (Qiagen).
Briefly, cell pellets were resuspended in buffer P1 (Qiagen) followed by adding buffer P2 and
N3 (Qiagen). The lysed cells were cleared by centrifugation (13000 rpm, 15 min). The super-
natant containing DNA was processed for DNA extraction using isopropanol precipitation.
The DNA was washed with 70% ethanol and resuspended in water.
To generate V0 baculoviruses, about 1 million Sf9 cells were seeded in 1 well of a 6-well plate
using Sf900 II SFM (Gibco) medium. DNAs (bacmids) were transfected to the adherent Sf9
cells using X-tremeGENE 9 DNA Transfection Reagent (Sigma-Aldrich). Transfection effi-
ciency was monitored by YFP signal using a fluorescent microscope. V0 viruses were har-
vested 72 h after transfection and applied to produce V1 viruses using infection of 50 ml of
Sf9 suspension culture. V1 viruses were harvested 48 h after proliferation arrest and stored at
4 °C in dark.
2.2.2 Protein expression in insect cells
For protein expression, 600 ml (1×106 cells ml-1) of Sf9 cells (grown in Sf900 II SFM [Gibco]
medium) or Hi5 cells (grown in ESF921 medium [Expression Technologies]) were infected
with 500-1000 μl of V1 virus. To assess the protein expression level in cells, YFP expression
was measured. Briefly, 500 μl of cells were collected at different time points and the intensity
of YFP signals measured using a Victor X3 multi-label plate reader (PerkinElmer). After pro-
liferation arrest, YFP signal was increased and then dropped (48-72 h after proliferation ar-
rest). Cells were harvested by centrifugation (4000 rpm, 4 °C, 30 min), washed with 1x PBS,
snap frozen, and stored at -80 ºC.
The expression levels and stability of different proteins were evaluated in Sf9 and Hi5 cells
using SDS page and Coomassie blue staining. Based on the results, Hi5 cells were chosen for
expression of truncated Esco2 and Sf9 for expression of other proteins in this study.
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Protein purification
2.3.1 Purification of mouse Esco2368-592
MmEsco2368-592 recombinant protein was purified using anion exchange chromatography fol-
lowed by affinity chromatography and size-exclusion chromatography. Briefly, the cell pellet
was thawed from -80 °C and resuspended in lysis buffer (50 mM HEPES pH 7.2, 200 mM
NaCl, 10% glycerol, 2 mM DTT and complete EDTA-free protease inhibitors cocktail
[Roche]) and lysed 3 times using a Microfluidizer (Micro fluidics). The lysate was cleared by
centrifugation (10000 rcf, 4 °C, 30 min) and the supernatant was applied onto a 50 ml anion-
exchange Q-Sepharose column (GE Healthcare) equilibrated with lysis buffer. The column
was washed with 10 column volumes of lysis buffer. The bound proteins were eluted with a
linear gradient from 100 mM to 1 M NaCl. Different fractions were analyzed by SDS-PAGE
and Coomassie blue staining. The peak fractions containing Esco2 were pooled and applied
onto a 1 ml nickel- nitrilotriacetic acid (Ni-NTA) Superflow column (Qiagen), equilibrated
with 20 mM HEPES pH 7.2, 500 mM NaCl, 10% glycerol, 2 mM DTT and 10 mM imidazole.
The column was washed with 10 column volumes of buffer containing 10 mM imidazole. The
nickel bound proteins were eluted with a linear imidazole gradient of 15-250 mM. The peak
fractions were analyzed by SDS-PAGE and Coomassie blue staining. The corresponding frac-
tions were pooled, concentrated to the volume of 2 ml using centrifugal filters (10-kDa con-
centrator; Amicon Ultra, Millipore) and applied onto a S75 16/600 pg size exclusion column
(GE Healthcare), equilibrated with 10 mM HEPES pH 7.2, 150 mM NaCl, 5% glycerol and 2
mM DTT. Peak fractions were analyzed by SDS-PAGE and Coomassie blue staining, concen-
trated and flash frozen, and stored at −80 °C. Single point Esco2 mutants were purified using
the same strategy described above. A list of buffer solutions applied for this purification is
shown in Table 2.
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2.3.2 Purification of full-length human ESCO1
500 µl of Ni-NTA agarose beads (Qiagen) were washed 3 times and equilibrated with lysis
buffer (20 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, 30 mM imidazole, 1 mM TCEP
and complete EDTA-free protease inhibitors cocktail [Roche]) and used for 5 ml of cell pellet.
Frozen cell pellets were thawed and resuspended in lysis buffer (20 mM HEPES pH 7.5, 300
mM NaCl, 10% glycerol, 30 mM imidazole, 1 mM TCEP and complete EDTA-free protease
inhibitors cocktail [Roche]) and lysed by sonication (60 s “on” 30 % amplitude and 60 s “off”,
repeated 3 times) (Branson Ultrasonics™ Sonifier Modell 250 CE). The lysate was cleared by
centrifugation (7500 rcf, 4 °C, 30  min [after 15 min spinning was stopped, the supernatant
transferred to a fresh tube for an extra 15 min of centrifugation]). Subsequently, the superna-
tant containing HsESCO1 was filtered using 0.8 μm filters (Millipore) and incubated with
equilibrated Ni-NTA beads for 2 h at 4 °C. Ni-NTA beads were washed with 10 bead vol-
umes (BV) of lysis buffer, followed by 10 BV of high salt buffer (20 mM HEPES pH 7.5, 1
M NaCl, 10% glycerol, 30 mM imidazole and 1 mM TCEP), lysis buffer (20 mM HEPES pH
7.5, 300 mM NaCl, 10% glycerol, 30 mM imidazole and 1 mM TCEP) and finally low salt
buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 30 mM imidazole and 1 mM
TCEP). Bound proteins to Ni-NTA beads were eluted with lysis buffer containing 150 mM
NaCl, 500 mM imidazole and dialyzed for 16 h against dialysis buffer (20 mM HEPES pH
7.5, 100 mM NaCl, 10% glycerol, 1 mM DTT). The dialyzed samples were aliquoted and
snap-frozen. HsESCO1 mutants were expressed and purified as described for wild type
HsESCO1.
Lysis buffer Elution buffer
50mM Hepes 7.2 50mM Hepes 7.2
200mM NaCl 1 M NaCl
10% glycerol 10% glycerol
2mM DTT 2mM DTT
Lysis buffer Elution buffer
20mM Hepes 7.2 20mM Hepes 7.2
500mM NaCl 1 M NaCl
10% glycerol 10% glycerol
10mM imidazol 250mM imidazol
2mM DTT 2mM DTT
buffer
10mM Hepes 7.2
150mM NaCl
5% glycerol
2mM DTT
A B C
Table 2: List of buffer solutions applied in MmEsco2368-592 purification.
(A) Anion Exchange Chromatography buffers. (B) Affinity chromatography buffers. (C) Gel filtration
buffer.
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2.3.3 Purification of trimeric and tetrameric cohesin complex
Trimeric cohesin complexes were expressed in Sf9 cells using coinfection with Smc1-His and
Smc3-FLAG and Scc1-MBP viruses. Cells were lysed in lysis buffer (20 mM HEPES pH 7.5,
500 mM NaCl, 10% glycerol, 1 mM DTT and complete EDTA-free protease inhibitors cock-
tail [Roche]) supplemented with 0.02% NP40 and 1 mM PMSF. After sonication and clarifi-
cation (centrifugation at 8500 rcf, 4 °C, 60  min), the lysate was applied onto a 5 ml amylose
column (GE Healthcare) and equilibrated with lysis buffer. The bound proteins were eluted
with a linear gradient of 10-100 mM maltose. The peak fractions were pooled, concentrated
and applied onto a S200 16/600 pg size exclusion column (GE Healthcare) and equilibrated
with 10 mM HEPES pH 7.2, 150 mM KCl, 5% glycerol and 2 mM DTT. Peak fractions were
concentrated, flash frozen and stored at −80 °C. The Tetrameric cohesin complexes were ex-
pressed in Hi5 cells using coinfection with Smc1, Smc3-FLAG, Scc1, His-SA1 viruses. Cells
were lysed in lysis buffer (50 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, 2 mM DTT,
30 mM imidazole and complete EDTA-free protease inhibitors cocktail [Roche]) supplement-
ed with 1 mM TCEP, 1 mM Pefabloc and 0.05% Tween-20. After sonication (60 s “on” 30%
amplitude and 60 s “off”, repeated 3 times) and clarification (centrifugation at 8500 rcf, 4 °C,
60  min), the supernatant containing the tetramer was filtered using 0.8 μm filters (Millipore).
Subsequently, the lysate was incubated with 1 ml of Ni-NTA beads for 2 h at 4 °C. Ni-NTA
beads were washed with 10 bead volumes (BV) of lysis buffer, followed by 10 BV of high
salt buffer (50 mM HEPES pH 7.5, 1 M NaCl, 10% glycerol, 30 mM imidazole and 0.01%
Tween-20), lysis buffer (50 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, 30 mM imid-
azole and 0.01% Tween-20) and finally low salt buffer (50 mM HEPES pH 7.5, 150 mM
NaCl, 10% glycerol, 30 mM imidazole and 0.01% Tween-20). Bound proteins to Ni-NTA
beads were eluted with lysis buffer containing 150 mM NaCl and 250 mM imidazole. Eluates
were incubated with 200 µl of anti-FLAGM2 agarose beads (Sigma) for 2 h at 4 °C. Beads
were washed with washing buffer (25 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1
mM DTT and 0.01% Tween-20). The complex was eluted in elution buffer (25 mM HEPES
pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT and 0.5 mg ml-1 FLAG peptide).
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Characterization of purified proteins
2.4.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
Proteins were separated by SDS-PAGE according to their size using 4-15% Mini-
PROTEAN® TGX™ precast protein gels and the Mini-PROTEAN® tetra cell systems cham-
bers (Biorad). Gel electrophoresis was carried out with 1x Tris/glycine/SDS running buffer at
250 volts for 30 to 45 min. Protein subunit size was estimated using a prestained protein
marker (ThermoFisher). 0.8 and 3 µl of this marker were used for Coomassie and silver stain-
ing, respectively.
2.4.2 Protein staining
Protein gels were either stained using Coomassie or silver staining. To stain with Coomassie,
staining solution (0.1% Coomassie brilliant blue R-250, 40% methanol and 10% glacial acetic
acid) was added to the gel and put into a microwave at 900 watts for 40 seconds to 1 minute
(until the Coomassie stain solution boiled). The gel was then incubated in the Coomassie solu-
tion for 10 minutes to overnight on a rocking table. Fresh destaining solution (40% methanol
and 10% glacial acetic acid) was added to the gel and put into the microwave at 900 watts for
40 seconds to 1 minute (until the destaining solution boiled). The gel was incubated for 10
minutes in the destaining solution on a rocking table. Destaining was repeated until a suffi-
cient level of destaining was reached.
To stain with silver, the gel was incubated for 60 minutes to overnight in the fixing solution
(50% methanol and 10% glacial acetic acid). After fixing, silver staining was done according
to the manufacturer’s manual (ProteoSilver silver stain kit, Sigma).
2.4.3 Protein concentration measurement
The concentrations of protein solutions were determined by NanoDrop 2000 (Thermo Fisher
Scientific) using the protein specific extinction coefficient and molecular weight. A dilution
series of bovine serum albumin (BSA) (67 kDa, NEB) was used as standard to estimate the
concentration of low quantities of purified proteins.
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Crystallization and structure determination
MmEsco2368-592 was crystallized using the sitting-drop vapor-diffusion method at 20 °C, using
a Cartesian liquid dispensing robotic device. Different commercial crystallization reagents
were screened to identify initial conditions. Crystals were obtained from droplets consisting of
100 nl of MmEsco2368-592 (in buffer with 10 mM HEPES pH 7.2, 150 mM NaCl, 5% glycerol
and 2 mM DTT) and 100 nl reservoir solution. The crystal growth was monitored by imaging
with RockImager. After harvesting, crystals were cryoprotected in 15–20% ethylene glycol
and flash frozen in liquid nitrogen.
Diffraction data were collected at beamline PXII of SLS (Paul Scherrer Institute, Villigen,
Switzerland), processed and scaled using XDS (Kabsch, 2010). By making use of the natively
bound zinc ion, the crystal structure was determined by single-wavelength anomalous disper-
sion (SAD) from a dataset collected at the zinc peak wavelength.
The final model was built manually using COOT32 (Emsley et al., 2010) and structure re-
finement was performed with Phenix33 (Adams et al., 2010).
In vitro acetylation assay
Acetylation assays were performed by preincubation of 100-500 nM of trimer (dependent on
the experiment) or 100 nM of tetramer with 240 µM ATP, 10 µM AcCoA, 3.3 nM pcDNA3.1
plasmid, 25 mM HEPES pH 7.5, 25 mM NaCl, 1 mM MgCl2 and 0.05 mg ml-1 BSA at 32 °C.
After 1 h, 50 nM HsESCO1 and additional NaCl to the final concentration of 100 mM were
added for further incubation at 37 °C. The reactions were stopped at the different time points
by adding an equal volume of 2X SDS loading buffer, and denatured at 100 °C for 5 min.
SMC3 acetylation was detected using immunoblotting and AcSmc3-specific antibody. Quan-
tification was performed using ImageQuant software (GE Healthcare).
In vitro acetylation assays using MmEsco2368-592 and different lengths of the Smc3 peptides
(14 residues; RVIGAKKDQYFLDK, 24 residues: EEVSLRRVIGAKKDQYFLDKKMTK
and 29 residues: DNRLPIDKEEVSLRRVIGAKKDQYFLDKKMTKNDVMNLLES) were
performed with incubation of 5µM of enzyme and 50 µM of peptide in buffer (50 mM Tris-
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HCl, pH 7.9, 0.1 mM EDTA, 1 mM DTT, 50 μg/ml acetylated BSA and 20 µM [14C] AcCoA)
for 2 h at 30°C.
Cell culture, transfection and synchronization
Wild type MmEsco1 was cloned into a pEF6/Myc-His B vector using standard restriction-
ligation methods and KpnI/EcoRV restriction enzymes (NEB). Point mutations in MmEsco1-
myc/His were introduced with the QuikChange II XL site-directed mutagenesis kit (Agilent
Technologies). Immortalized MEFsEsco1-/-  in standard medium (DMEM, supplemented with
10% fetal bovine serum [FBS], 100 U/ml penicillin and 100 µg/ml streptomycin [all Thermo
Fisher Scientific]) were transiently transfected with the wild type and mutant versions of
MmEsco1 constructs using Lipofectamine LTX Reagent (Thermo Fisher) according to the
manufacturer’s manual with minor changes. In summary, 0.7×105 cells were seeded in one
well of a 6-well plate. After 24 h, cells were transfected with 3 µg of plasmid DNA. To syn-
chronize cells in G1, 36 h after transfection, the medium was changed to DMEM medium
supplemented with 10% FBS and 25 µM lovastatin. Cells were harvested after 24 h (G1) and
synchronization was assessed by flow cytometry. Subsequently, the transfection efficiency of
the cells was monitored using western blotting with Esco1-specific antibody that can detect
endogenous levels of the protein. Cells expressing MmEsco1 close to endogenous levels of
MmEsco1 were taken for further analysis.
Wild type MmEsco2-myc/his and H2B-mCherry were cloned into the pVITRO2-hygro-mcs
vector in two steps. First, full-length MmEsco2 was cloned into the pcDNA3.1/myc-His vec-
tor. Subsequently, MmEsco2-myc/his and H2B-mCherry were amplified from the vectors
pcDNA3.1/myc-His and pcDNA3 (Addgene), respectively, and cloned into the pVITRO2-
hygro-mcs vector. Point mutations in MmEsco2-myc/his were introduced with the Quik-
Change II XL site-directed mutagenesis kit (Agilent Technologies). Primary MEFsEsco2fl/fl
were isolated from E12.5 embryos following standard procedures and immortalized by serial
passages. To delete exon 2 and 3 of Esco2, immortalized MEFsEsco2fl/fl were grown to conflu-
ence in standard medium (DMEM, supplemented with 10% FBS, 100 U/ml penicillin and 100
µg/ml streptomycin [all Thermo Fisher Scientific]) at 37 °C in a humidified incubator with
5% CO2. After reaching confluency, cells were transduced with Ad-Cre-GFP adenoviruses
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(SignaGen) in low serum medium containing 3% FBS (Figure 6). After two days, the medium
was changed to fresh low-serum medium and cells were cultured for another 48 h. Immortal-
ized MEFsEsco2-/- were stably transfected with wild type and mutant versions of MmEsco2 us-
ing Hygromycin selection. Clones that stably expressed the mutants close to the endogenous
level were selected using western blotting and MmEsco2-specific antibody sensitive enough
to detect endogenous protein levels. For synchronization, cells were treated twice with 2 mM
thymidine for 14 h with an intermittent release of 9 h. Cells were harvested 2 h after the sec-
ond thymidine release and further processed for subsequent analyses.
Flow cytometry
To confirm cell cycle synchronization , an aliquot of collected cells (5×105) was analyzed for
DNA content by flow cytometry. Cells were fixed for at least 30 min in 70% ethanol at -
20 °C. Subsequently, cells were washed with cold 1x phosphate-buffered saline (PBS) sup-
plemented with 5% FBS (resuspension and centrifugation at 1000 g, 4 °C) and stained with
500 µl of FxCycle™ PI/RNase Staining Solution (Thermo Fisher Scientific) for 30 min at
room temperature. Samples were analyzed using the Accuri C6 Flow Cytometer (BD).
Cell extract preparation and immunoblotting
For whole-cell extracts, cells were collected, washed in cold 1x PBS, resuspended in 2X SDS
loading buffer and sonicated in an ultrasonic bath for 15 min. Chromatin fractionation was
Figure 6. Generation of MEFsEsco2-/- from MEFsEsco2 fl/fl.
MEFsEsco2fl/fl were transduced with Ad-Cre-GFP to delete exon 2 and 3 of Esco2. Efficiency of
transduction was assessed by monitoring GFP fluorescence using a fluorescent microscopy (left).
Wild type and knock out cells were PCR-genotyped using published primers (Whelan et al.,
2012) to confirm their genotype (right).
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performed according to the protocol described by Mendez and Stillman (2000) with minor
modifications. Briefly, cells (1.2×106 cells) were washed twice with cold 1x PBS and lysed
with 200 µl buffer A (10 mM HEPES pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose,
10% glycerol, 1 mM DTT and complete EDTA-free protease inhibitors cocktail [Roche]).
Subsequently, Triton X-100 (0.1%) was added, and the cells were incubated for 8 min on ice.
Nuclei were collected in pellet 1 (P1) by low-speed centrifugation (5 min, 1300 g, 4 °C). The
supernatant (S1) was further clarified by high-speed centrifugation (5 min, 20000 g, 4 °C) to
remove cell debris. Pellet 1 (nuclei) was washed once in 200 µl buffer A, and then lysed in
100 µl buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT and complete EDTA-free prote-
ase inhibitors cocktail [Roche]). Cells in buffer B were incubated for 30 min at 4 °C on a ro-
tating wheel. The insoluble chromatin was collected by centrifugation (5 min, 1700 g, 4 °C),
washed once in 100µl buffer B, and centrifuged again under the same conditions. The final
chromatin pellet (P3) was denatured in 2X SDS loading buffer and sonicated in an ultrasonic
bath for 15 min. Cytoplasmic (S1), nucleoplasmic (S2) and chromatin fractions (P3) were
analyzed by western blotting. Signal intensities were detected by ImageQuant LAS4010 im-
ager (General Electric) and quantified using ImageQuant software.
Prometaphase chromosome spreads, cytospin and immunofluores-
cence analysis
MEFs were grown in T-75 flasks with standard culture medium (DMEM, supplemented with
10% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin [all Thermo Fisher Scientific]).
Cells with 60 % confluency were arrested using nocodazole (400 ng ml-1) for 4 h. Mitotic
cells were harvested by shaking off and incubated with 1 ml of 75 mM KCl for 20 min at 37
°C. Prometaphase chromosomes were fixed by adding 1 ml of the fixing solution (methanol:
acetic acid [3:1]), washed 6 times with fixing solution and dropped onto humidified positively
charged microscope slides (VWR). Prometaphase chromosome spreads were stained and
mounted using Vectashield mounting medium with DAPI (Vector Laboratories) and visual-
ized using a Leica fluorescence microscope. For immunofluorescence on prometaphase chro-
mosomes, mitotic cells were spun onto poly-L-lysine coated coverslips at 1000 rpm for 10
min using a Cytospin-4 centrifuge (Shandon) after incubation with 75 mM KCl. Cells were
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pre-extracted with 0.5% Triton X-100 in 1x PBS for 5 min at 4 °C and fixed in 4% paraform-
aldehyde (PFA) in 1x PBS for 20 min at RT. Fixed cells were incubated further in blocking
reagent (5% BSA, 0.1% Tween-20 in 1x PBS) followed by incubation with Aurora B anti-
body and a fluorescent secondary antibody. Nuclei were stained with DAPI.
Statistical analysis
Statistical analysis was conducted using GraphPad Prism software (version 5.04). All data are
presented as means ± SEM.
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Results
Expression, purification and crystallization of the MmEsco2 protein
To gain insights into the structure and catalytic mechanism of an enzyme, crystallization and
X-ray structure determination are essential. This requires sufficient amounts of highly pure
recombinant protein. Protein expression in Escherichia coli is a fast, cost-efficient, and well-
established method. To produce soluble Esco2 protein, full-length N-terminal or C-terminal
His-tagged mouse or human Esco2 (592 and 601 amino acids long, respectively) were ex-
pressed in E. coli. Protein Expression was analyzed by SDS-PAGE following Coomassie blue
staining and Western blotting. The results showed that all these constructs were poorly ex-
pressed in E. coli (data not shown). This could be explained by the lack of specific chaperon
systems or the absence of post-translational modifications required for protein stability
(Trowitzsch et al., 2010). Likewise full-length proteins (Figure 7A, top) were poorly ex-
pressed in Sf9 and Hi5 insect cells (not shown) which prompted us to produce several frag-
ments which included the acetyltransferase (ACT) domain and the N-terminally located C2H2
zinc finger (ZnF) (Figure 7A). These MmEsco2 fragments were expressed in Sf9 and Hi5
insect cells. A high yield was obtained with the C-terminal His-tagged MmEsco2368-592 con-
struct in Hi5 cells (Figure 7B). This fragment was also soluble (Figure 7C) and migrated in
SDS-PAGE at the predicted molecular mass of approximately 28 kDa (Figures 7B and 7C).
Hence large-scale of MmEsco2368-592 expression was performed in 1 L Hi5 cells. Cell extracts
were sequentially purified starting with anion exchange chromatography followed by a Ni-
NTA affinity column and size-exclusion chromatography (Figures 8A - 8C). This resulted in a
pure 28 kDa MmEsco2368-592 recombinant protein (Figure 8C) as judged by SDS-PAGE
stained with Coomassie blue and on a Western blot with a His-antibody (Figure 8C). Note
that MmEsco2368-592 is positively charged and does not bind to the anion exchange resin. This
allows the removal of the majority of nucleic acid contaminants and leads to partial purifica-
tion of MmEsco2368-592 from crude extract (Figure 8B). Ni-affinity chromatography further
separated MmEsco2368-592 from contaminant proteins and MmEsco2368-592 eluted sharply from
the Ni-NTA column with increasing imidazole concentration (Figure 8B). Size exclusion
chromatography on Superdex 75 yielded approximately 0.4 ml of a pure fraction of
MmEsco2368-592 at a concentration in a range of 10 mg/ml. This efficient 3-step purification
and a high purity of MmEsco2368-592 provided a good resource for subsequent crystallization
experiment for MmEsco2368-592.
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Figure 7: Expression of MmEsco2 in insect cells and sequence alignment of ACT domains from
various species.
(A) Scheme of MmEsco2 indicating the zinc-finger (ZnF) and the acetyltransferase (ACT) domain. Full-
length and different truncated variants of MmEsco2 with N- or C-terminal His-tag were designed for ex-
pression in insect cells. (B) Comparison between the expression of MmEsco2368-592 in Sf9 and Hi5 insect
cells at different time points after virus infection. Expression of protein was analyzed by Western blotting -
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Next, initial crystallization conditions were determined. Several commercially available kits
were used, each of which consists of 96 different crystallization conditions (variables are salt
type, precipitant, additive, pH etc.). Kits used were Classics™, Classics Lite™, PEGs™,
NH4SO4, Anions™, Cations™, ComPAS™, pH Clear I™, pH Clear II™, Index screen™ and
Wizard 1™ and Wizard 2™. Crystallization experiments for MmEsco2368-592 were performed
at 20 °C with the sitting-drop vapor-diffusion method using a Cartesian liquid dispensing ro-
using His-antibody. (C) Monitoring expression and solubility of MmEsco2368-592 in Hi5 insect cells. Ex-
pression of protein was analyzed by SDS-PAGE followed by Coomassie blue staining. CE: cell extrac-
tion; S: soluble fraction; DPA: days post anthesis. (D) Sequence alignment of Esco2 orthologs. Sequenc-
es shown are Homo sapiens ESCO1 (Hs), HsESCO2, Mus musculus Esco1(Mm), MmEsco2, Xenopus
laevis Eco2 (Xl) and S. cerevisiae Eco1 (Sc). Strictly conserved residues are highlighted in red, and high-
ly conserved residues are boxed. Numbering and secondary structural elements above the sequence
alignment are shown for MmEsco2368-592. Dashed lines show the disordered regions. Blue circles high-
light residues presumed to be important for catalysis. Pink squares highlight residues mutated in Roberts
syndrome. Sequence alignments were illustrated using ESPript (Gouet et al., 1999).
Figure 8: Purification of recombinant MmEsco2368-592.
(A) Scheme of the MmEsco2368-592 purification steps. (B) Purification of MmEsco2368-592. The protein was puri-
fied in three subsequent steps using anion-exchange (Q-Sepharose), affinity (Ni-NTA) and size exclusion (Su-
perdex 75) chromatography. The peak fractions after each step were analyzed by SDS-PAGE followed by Coo-
massie blue staining. The band corresponding to MmEsco2368-592 is indicated on the right side. The masses of the
molecular weight markers (kDa) are indicated on the left side. (C) The peak fractions from size exclusion (Su-
perdex 75) chromatography were analyzed by SDS-PAGE followed by Coomassie blue staining (left) or West-
ern blotting using anti-His-antibody (right).
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botic device. Crystals appeared after 3 days from droplets in pH Clear I screen plates. 100 nl
of 10 mg/ml MmEsco2368-592 in buffer (10 mM HEPES pH 7.2, 150 mM NaCl, 5% glycerol
and 2 mM DTT) was mixed with an equal volume of pH Clear I solution in the reservoir.
Crystals grew optimally in the presence of 100 mM Tris, 20% (v/v) 2-Methyl-2,4-pentanediol
(MPD) at pH 8. They had a conical appearance and a length of up to 580 µm (Figure 9).
Grown crystals were harvested and cryoprotected in 15–20% ethylene glycol and flash frozen
in liquid nitrogen. Diffraction data were collected at beamline PXII. Crystals diffracted up to
1.8 Å resolution. Initial molecular replacement attempts using published Gcn5-related N-
acetyltransferases (GNAT) protein structures (PDB ID code 1QST) as model were unsuccess-
ful to provide electron density maps suitable for model building. By making use of the native-
ly bound zinc ion, the crystal structure was determined by single-wavelength anomalous dis-
persion (SAD) from a dataset collected at the zinc peak wavelength. Crystal structure data are
summarized in a table (Table 3).
Figure 9: MmEsco2368-592 crystal.
Image of a typical MmEsco2368-592 crystal obtained in a pH Clear I
screen plate, consisting of equal volumes of MmEsco2 (10 mg/ml)
and reservoir solution (100 mM Tris, 20% (v/v) MPD, pH 8). Scale
bar: 100 µm.
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Native I - Zn K-Edge Native II
Data collection
Space group P43 P43
Cell dimensions  
a, b, c (Å) 52.6, 52.6, 106.1 52.7, 52.7, 107.5
    a, b, g  (°) 90, 90, 90 90, 90, 90
Wavelength 1.28 1.0
Resolution (Å) 50.0-2.3 (2.3) 50-1.8 (1.8)
Rsym 2.1 (50.8) 4.7 (29.9)
I / sI 90.8 (4.1) 31.7 (4.8)
Completeness (%) 98.7 (99.1) 99.2 (98.0)
Redundancy 7.0 (7.1) 3.4 (3.5)
CC(1/2) 100 (93.6) 99.5 (95.7)
Refinement
Resolution (Å) 47.4-1.8
No. reflections 26908
Rwork / Rfree 18.5/21.1
No. atoms
    Protein 1581
Ligand 49
    Water 21
B-factors
Protein 36.4
    Ligand 30.1
Water 34.5
R.m.s deviations
Bond lengths (Å) 0.019
    Bond angles (°)
Ramachandran
favored (%)
allowed (%)
outliers (%)
1.9
98.5
1.0
0.5
Table 3: Data collection, phasing and refinement statistics.
One crystal was used for each dataset. Values in parentheses are for highest-resolution shell.
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Overall structure of the MmEsco2368-592 in complex with Coenzyme
A (CoA)
The refined MmEsco2368-592 /CoA structure revealed continuous electron density from amino
acids 368 to 592, except for two short unresolved regions (residues 368-383 and 501-514),
likely because these regions are structurally disordered (Figure 7D). Residues 423-592 of
MmEsco2368-592 adopt an overall fold that shares many common features with other acetyl-
transferases of the GNAT family (Salah Ud-Din et al., 2016) (Figure 10A). This fold includes
a structurally conserved core region, consisting of β5, β6, β7, α3, and α4, which is flanked by
structurally variable regions, likely responsible for substrate binding (Salah Ud-Din et al.,
2016) (Figure 10A). The CoASH cofactor is natively present in a complex with MmEsco2 in
a groove formed by β7 and β8 strands and α3 and α4 helices (Figures 10A and 10C), similar
to the position of the CoA/Acetyl-CoA cofactor bound to other GNAT family members (Salah
Ud-Din et al., 2016) (Figure 3). The zinc finger domain (residues 385-416), located N-
terminally of the catalytic domain, consists of two β-strands and one α-helix and folds around
the zinc ion, which is coordinately bound to the protein through four residues (C386, C389,
H404 and H407) (Figure 10B).
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Figure 10: Structure of the MmEsco2368-592/CoA Complex.
(A) Ribbon representation of the MmEsco2368-592/CoA complex. α-Helices are shown in blue, β-strands in rasp-
berry, and loop regions in grey. CoA is represented as sticks and colored according to elements: carbon, green,
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nitrogen, blue; sulfur, yellow; oxygen, red and the zinc ion shown as a magenta sphere. (B) Zinc finger residues
involved in zinc ion ligation are labeled. (C) CoA interactions with its binding residues in MmEsco2. Residues
located on β-sheets are highlighted in raspberry, residues located on α-helices are highlighted in blue, residues
located on loops are highlighted in grey. Green dashed lines indicate hydrogen bonds. The hydrophobic contacts
are represented by arcs with spokes radiating towards the CoA. The diagram was generated using LigPlot
(Wallace et al., 1995). (D) Stereo view of the MmEsco2368-592/CoA complex structure. The CoA cofactor is
located in a groove formed by β7 and β8 strands and α3 and α4 helices.
Active site architecture and implications for catalysis
To begin to characterize the active site of MmEsco2, we chose a number of potential catalytic
residues which could serve as general base/acid and proton shuttle (see Introduction section
1.2.3). This selection was based on the MmEsco2368-592/CoA complex structure and took into
consideration side chain orientations and proximities of the candidate residues relative to the
acetyl group of AcCoA (Figures 11A and 11B). The most obvious candidate residues are ser-
ine 566 and aspartate 567, which are located at the C-terminus of the β8 strand and in a loop
between β8 strand and α3 helix, respectively (Figures 11A). The β-hydroxyl group of S566
and γ-carboxyl group of D567 are ~ 6 and ~ 7.6 angstrom (Å) away from the carbonyl carbon
of AcCoA, respectively (Figures 11A and 11B). In addition, we considered serine 527, which
is in the middle of β7 (Figure 11A). The β-hydroxyl group of this serine is ~ 7.9 Å away from
carbonyl carbon of AcCoA (Figures 11A and 11B). Finally, we considered E491, which re-
sides at the end of the β6 strand (Figure 11A). The δ-carboxyl group of E491 is ~ 9.6 Å away
from carbonyl carbon of AcCoA (Figures 11A and 11B). Also, note a water molecule located
between these four residues and CoA, which might be involved in proton transfer from the ε-
amino groups of substrate lysines to the catalytic residues (Figure 11C). Additional support
for the engagement of these candidate residues in catalysis is coming from superposition of
the structures MmEsco2/CoA with HsESCO1/AcCoA, xEco2/K105-CoA and xEco2/K106-
CoA (Figures 12 and 13). Positioning of putative catalytic residues of MmEsco2 toward the
AcCoA in HsESCO1/AcCoA and toward the K105 and K106 of the Smc3 peptide model sub-
strate in xEco2/K105-CoA and xEco2/K106-CoA allows a more educated depiction of the
candidates in the context of their model substrate. Further evidence for the importance of
these four residues we chose for enzyme activity is coming from their strict and high conser-
vation among Esco2 orthologs. E491, S527 and S566 residues are strictly conserved among
Esco homologs. D567 residue is also highly conserved except in yeast Eco1 (Figure 7D).
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Engagement of the D567 residue in catalysis has been also shown for its structurally equiva-
lent residue (D157) in HsαTAT1 acetyltransferase (Szyk et al., 2014), a member of the GNAT
family that shows a high structural similarity to MmEsco2 (Figure 14). However, superposi-
tion of MmEsco2/CoA and XEco2/K105-CoA suggests that D567 is also well positioned to
play a role in substrate recognition and binding (Chao et al., 2017b) (Figure 12A).
In summary, our structure together with the comparison to other structures of related acetyl-
transferases identifies four putative catalysis-relevant residues in MmEsco2. Given the prece-
dent of multiple side chains participating in acetyl transfer (See introduction section 1.2.3) we
cannot a priori rule out a similar mechanism for MmEsco2.
To investigate the functional importance of these catalytic candidate residues, we performed
site directed mutagenesis.
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Figure 11: Active site of MmEsco2.
(A) Close-up view of the active site of the MmEsco2368-592/AcCoA model (the acetyl moiety was modeled
based on superimposition of MmEsco2368-592/CoA and HsαTAT1/AcCoA [PDB ID code 4GS4]). Putative
catalytic residues are labeled. Dashed lines indicate the distance in Ångström (Å) of putative catalytic
residues to the acetyl group of AcCoA. (B) 2D schematic diagram showing the distances of S566, S527,
D567 and E491 from AcCoA. (C) Close-up view of the active site of MmEsco2368-592/CoA showing a
water molecule located between the catalytic candidate residues and CoA. The water molecule is well
positioned to allow proton transfer. (D) Numbering of equivalent putative catalytic residues of MmEsco2
in MmEsco1 and HsESCO1.
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Figure 12: Close-up view and comparison of the active sites of MmEsco2/CoA, xEco2/K105-CoA and
xEco2/K106-CoA.
(A) Putative catalytic residues of MmEsco2 (green) and xEco2/K105-CoA (blue; PDB ID code 5N1W) are
shown as sticks. K105 in the Smc3 peptide model substrate is shown in raspberry. (B) Putative catalytic residues
of MmEsco2 (green) and xEco2/K106-CoA (orange; PDB ID code 5N22) are shown as sticks. K106 of the
Smc3 peptide is shown in yellow. Active site architecture and positioning of putative catalytic residues of
MmEsco2 show high structural homology to xEco2.
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Figure 13: Close-up view of the active sites of
MmEsco2/CoA and HsESCO1/AcCoA.
Putative catalytic residues of MmEsco2 (green) and HsESCO1
(raspberry; PDB ID code 4MXE) show high structural conser-
vation.
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Effect of site-directed mutagenesis of the active site residues on
acetyltransferase activity of Esco1 and Esco2
3.4.1 Expression and purification of HsESCO1 and HsESCO2
Based on the structure of murine Esco2 and on previously published GNAT acetyltransferase
studies (Friedmann et al., 2012; Rivera-Colon et al., 2016) we focused on mutations in serine
566 and the neighboring residue aspartic acid 567 (Figure 11A). All proteins were synthesized
in insect cells. While MmEsco2368-592 was capable of acetylating itself at several lysine resi-
dues, this reaction was slow with a half-time in the range of hours (see Appendix, Figures
29B and 29C). The Smc3 peptide could not be acetylated by MmEsco2368-592 although a hu-
man ESCO1 fragment (residues 590 – 840) was reported to acetylate this peptide albeit at a
slow rate (Rivera-Colon et al., 2016). In addition, Ladurner et al. (2014) showed that full-
length HsESCO1 is catalytically active and acetylates recombinant cohesin under in vitro
conditions.
Full-length, N-terminally His-tagged versions of HsESCO1, MmEsco1, HsESCO2,
MmEsco2, and of full-length His-MBP tagged HsESCO2 were expressed in Sf9 cells. They
all gave very low yields with the exception of His-tagged HsESCO1 and MBP-tagged
MmEsco2/CoA
D567
D157
HsαTAT1/K40-CoA peptide
K40
Figure 14: Close-up view of the active sites of
MmEsco2/CoA and HsαTAT1/K40-CoA.
Close-up view of the active sites of MmEsco2/CoA (green)
superimposed on structure of HsαTAT1/K40-CoA α-tubulin
peptide (sand; PDB ID code 4GS4). D567 of MmEsco2 and
D157 of HsαTAT1 show similar localization in the active
site.
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HsESCO2. Purification of these two recombinant proteins from a 500 ml culture was done
using affinity chromatography (Ni-NTA or amylose resin) (Figures 15A – 15C) and resulted
in µg amounts of protein (HsESCO1: 20 µg and HsESCO2: 2 µg). SDS-PAGE of HsESCO1
showed a strong band with a molecular mass of about 120 kDa (molecular weight of
HsESCO1 including His-tag and TEV recognition site was predicted as 100 kDa) which also
reacted with an Esco1 polyclonal antibody on a Western blot (Figure 15C). MBP-tagged
HsESCO2 was somewhat less pure and the yield was lower (Figure 15B, left lane). Therefore,
all experiments reported here were carried out with HsESCO1 whose active site is very simi-
lar to that of MmEsco2 (Figure 13).
Next, we generated mutants of the HsESCO1 enzyme to evaluate their catalytic activity. Mu-
tants S809A, S809C, D810A, and D810N (see Figure 11D for equivalent residues of
MmEsco1 and MmEco2) were purified using the purification procedure described above for
wild type HsESCO1 (Figures 15A and 15D).
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Figure 15: Purification of recombinant HsESCO1 and HsESCO2.
(A) Schematic presentation of the purification procedure for HsESCO1 and HsESCO2. (B) Purified HsESCO2
analyzed by SDS-PAGE followed by silver staining (SS) or Western blotting (WB) using MBP-specific anti-
body. The protein was detected as a protein band with a molecular mass of about 115 kDa (predicted: 110 kDa).
(C) Purified HsESCO1 analyzed by SDS-PAGE followed by Coomassie blue staining (CO) or Western blotting
(WB) using Esco1 antibody. The protein was detected as a protein band with a molecular mass of about 120
kDa. (D) Purified HsESCO1 mutants analyzed by SDS-PAGE followed by Coomassie blue staining. Asterisks
indicate contaminants in Coomassie blue stainings in C and D.
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3.4.2 Expression and purification of trimeric and tetrameric cohesin complexes
As noted above, autoacetylation of MmEsco2 and acetylation of the Smc3 peptide occurs at
low rates and it might therefore problematic to use these substrates in assessing changes in
activity evoked by site-directed mutagenesis of candidate catalytic residues. Moreover, it has
been shown that the ATPase activity residing in the cohesin subunit SMC3 is essential for
acetylation of this subunit by HsESCO1 (Ladurner et al., 2014). In addition, binding of DNA
to cohesin stimulates the ATPase activity of Smc3 (Camdere et al., 2015). It has also been
reported that the yeast ortholog of the subunit SA1/2 stimulates loading of cohesin onto DNA
and increases DNA-dependent ATP hydrolysis by cohesin (Murayama and Uhlmann, 2014).
Altogether, a more reliable assessment of Esco1-mediated catalysis is to use trimeric (SMC1,
SMC3, SCC1) or tetrameric (SMC1, SMC3, SCC1, SA1 or SA2) cohesin in the presence of
ATP and DNA.
To generate the physiological substrate of HsESCO1, trimeric and tetrameric human cohesin
complexes were reconstituted and purified. The trimeric human cohesin complex was ex-
pressed in Sf9 cells using coinfection of SMC1-His, SMC3-FLAG and SCC1-MBP viruses. A
two-step purification (amylose affinity chromatography and gel filtration) of the modified
trimer resulted in a stoichiometric and highly concentrated complex at an amount 900 µg. All
three subunits were detected using SDS-PAGE and Coomassie blue staining (Figures 16A –
16C).
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Tetrameric human cohesin complex was expressed in Hi5 cells using infection with a multi-
bac virus harboring a SMC1, SMC3-FLAG, SCC1 and His-SA1 expression cassette. The
complex was purified by two steps of affinity chromatography using Ni-NTA and anti-FLAG
M2 agarose beads. All four subunits of tetramer complex were detected using SDS-PAGE
followed by silver staining (Figures 17A and 17B). A final yield of about 20 µg was obtained.
Figure 16: Purification of the trimeric human cohesin complex.
(A) Scheme of the purification procedure for trimeric human cohesin. (B) Trimer complex migrates as a sharp
single peak purified on a HiLoad 16/600 Superdex 200 size exclusion column. mAu; milli absorbance units.
(C) Purified human trimeric human cohesin analyzed by SDS-PAGE followed by Coomassie staining. The
bands corresponding to SCC1, SMC1 and SMC3 are indicated on the right side. The masses of the molecular
weight marker (kDa) are indicated on the left side. The asterisk indicates a minor contaminant. In the scheme
of the subunit composition of trimeric cohesin SMC3, SMC1 and SCC1 are shown in blue, red and green re-
spectively.
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3.4.3 Establishment of in vitro cohesin acetylation by HsESCO1
Recombinant HsESCO1 was incubated with trimeric or tetrameric cohesin in the presence or
absence of ATP and of topologically different DNAs for 1 hr. SMC3 acetylation was assessed
by Western blotting using an AcSmc3 specific antibody (Nishiyama et al., 2010). These ex-
periments revealed that in the presence of ATP and DNA, SMC3 acetylation in both trimeric
and tetrameric cohesin is highly efficient (Figures 18A - 18C). ATP or DNA alone was not
sufficient to promote acetylation of SMC3 neither in trimeric nor tetrameric cohesin (Figures
18A and 18B). However, addition of DNA and ATP together enabled HsESCO1 to catalyze
SMC3 acetylation. Consistent with previous work (Ladurner et al., 2014), blocking ATPase
activity with ATP analogs abolished acetylation.
Figure 17: Purification of the tetrameric human cohesin
complex.
(A) Scheme of the tetrameric human cohesin purification
procedure. (B) Purified human tetrameric cohesin analyzed
by SDS-PAGE followed by silver staining. The bands cor-
responding to SCC1, SMC1, SMC3 and SA1 are indicated
on the right side. The masses of the molecular weight mark-
er (kDa) are indicated on the left. In the scheme of the sub-
unit composition of tetrameric cohesin SMC3, SMC1,
SCC1 and SA1 are shown in blue, red, green and yellow
respectively.
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Next, we determined the time course of HsESCO1-mediated SMC3 acetylation for both tri-
meric and tetrameric cohesin. The reaction was carried out in the presence of covalently
closed circular DNA, ATP and AcCoA and a 1:2 molar ratio of HsESCO1 to oligomeric co-
hesin. The results showed that the addition of the SA1 subunit strongly stimulates the rate of
SMC3 acetylation (Figures 19A and 19B).
Together, our in vitro acetylation experiments show that a combination of tetrameric cohesin,
DNA, and ATP provides a robust assay on HsESCO1 catalytic activity that can readily be
extended to enzyme assays of site-directed HsESCO1 mutants.
Figure 18: ATP and DNA stimulate acetylation of cohesin by HsESCO1.
 (A) The purified trimeric cohesin complex was incubated with HsESCO1 and AcCoA in the presence or ab-
sence of ATP and different topologies of the pcDNA3 plasmid including linear DNA [L], relaxed circular
DNA [R] or covalently closed circular DNA [C]. Different topologies of the DNA show a similar effect on
SMC3 acetylation. (B) The purified tetrameric cohesin complex was incubated with HsESCO1 and AcCoA in
the presence or absence of ATP and covalently closed circular DNA. (C) The purified trimeric cohesin com-
plex was incubated with HsESCO1 and AcCoA in the presence of ATP, adenylyl-imidodiphosphate (AMP-
PNP), Adenosine diphosphate (ADP) or Adenosine 5′-[γ-thio] triphosphate (ATP-γ-S). In the cohesin complex
models, Smc1, Smc3, Scc1, and SA1 subunits are shown in red, blue, green, and yellow, respectively.
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3.4.4 In vitro analysis of active site mutants of HsESCO1
We next quantified the rate of SMC3 acetylation by site-directed mutants of HsESCO1. We
focused on the S809 and D810 residues and incubated HsESCO1S809A, HsESCO1S809C,
HsESCO1D810A and HsESCO1D810N mutants (for residue equivalence see Figure 11D) with
cohesin complexes. Consistent with the above findings, wild type HsESCO1 efficiently acety-
lated trimeric and tetrameric substrates. In mutants, acetylation of SMC3 could neither be
detected with trimeric nor tetrameric cohesin substrates (Figures 20A - 20D). With the excep-
tion of the HsESCO1S809A mutant, HsESCO1 protein levels were similar (Figure 15D) to
those obtained with wild type HsESCO1. These four mutants also had previously been shown
to exhibit similar thermal stability to wild type protein arguing against the possibility that mu-
tant proteins were unfolded (Rivera-Colon et al., 2016). Importantly, wild type HsESCO1 was
able to acetylate SMC3 in the presence of HsESCO1 mutants such as HsESCO1D810N and
HsESCO1D810A (Figure 20E). Hence, we can rule out an inhibitory effect of impurities present
in mutant protein purifications. Furthermore, this experiment suggests that HsESCO1 mutants
did not act in a dominant negative fashion.
Together, these results indicate that both S809 and D810 are indispensable for the catalytic
activity of the HsESCO1 enzyme under in vitro condition.
Figure 19: SA1 subunit boosts cohesin acetylation.
(A) and (B) Time course quantification of SMC3 acetylation after incubation of purified trimeric or tetrameric
cohesin complexes with HsESCO1 in the presence of ATP, DNA and AcCoA. The level of SMC3 acetylation
level was analyzed by quantitative Western blotting using an AcScm3-specific antibody. Data were normalized
to the maximal signal seen for the tetramer. Data are shown as mean ± SEM (n = 2). Half-times for the tetramer
is ~ 20 min however, acetylation of the trimer acetylation is considerably slower.
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Effect of catalytic site mutants of Esco1 and Esco2 on in vivo acetyl-
transferase activity
In vitro assay with tetrameric cohesin shows efficient HsESCO1-mediated acetylation of the
SMC3 cohesin subunit but all mutations of candidate catalytic residues failed to acetylate
SMC3. This suggests that S809 and D810 are both indispensable for SMC3 acetylation. This
poses the question of whether that also holds true for catalytic activity in vivo where addition-
al cohesin components such as Wapl, Pds5A, Pds5B, SA1, SA2, Sororin and Nipbl are pre-
sent (Carretero et al., 2013; Nishiyama et al., 2010; Remeseiro et al., 2012; Remeseiro et al.,
2013; Tedeschi et al., 2013). Therefore, we used in vivo assays that assess Smc3 acetylation
Figure 20: S809 and D810 are crucial for HsESCO1 activity under in vitro condition.
Time course of SMC3 acetylation after incubation of purified trimeric cohesin (A) and (B) and tetrameric (C)
and (D) complexes with wild type or mutants HsESCO1. The molar ratio of HsESCO1 to trimer and tetramer
was 1:10 and 1:2 respectively. Relative intensity of SMC3 acetylation level was analyzed by quantitative West-
ern blotting using a specific AcSmc3 antibody. Data were normalized to maximal signal and are shown as mean
± SEM (n=2). (E) Test of whether contaminations of mutant protein preparation are inhibiting. The first 30 min
of incubation were with trimeric cohesin complex and wild type or mutant HsESCO1. In the subsequent second
incubation (30 min), wild type HsESCO1 was added to all reactions. Wild type enzyme produced acetylated
SMC3 although mutant enzyme was present.
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and sister chromatid cohesion in various mutants of MmEsco1/2 and MmEsco2 mouse em-
bryonic fibroblast, respectively.
3.5.1 Effect of catalytic site mutants of MmEsco1 on Smc3 acetylation in vivo
To investigate the activity of MmEsco1 mutants, we used a complementation assay in which
the capability of mutants in Smc3 acetylation were assessed in Esco1-deficient MEFs.
Esco1-deficient MEFs (MEFsEsco1-/-) were obtained from Esco1-/- mouse embryos. MEFsEsco1-/-
were transiently transfected with C-terminally myc-tagged MmEsco1, and the following myc-
tagged mutant constructs: MmEsco1S812A, MmEsco1S812C, MmEsco1D813A, and MmEsco1D813N.
Synchronization of cells in G1-phase showed that the mutations did not affect cell cycle pro-
gression (Figure 21A). Cells deficient for Esco1 showed a marked reduction in Smc3 acetyla-
tion compared to controls (Figures 21C and 21D). Residual Smc3 acetylation is likely due to
MmEsco2 that is present at low-amounts during the G1-phase (Lafont et al., 2010; Whelan et
al., 2012). Transfection with MmEsco1-myc resulted in strong Smc3 acetyl ation.
Transfection of MEFsEsco1-/- with different MmEsco1 single mutants showed that only
MmEsco1D813N could not restore Smc3 acetylation above background (Figures 21D and 21E).
In fact, MmEsco1D813A, MmEsco1S812A, and MmEsco1S812C showed 30-50% residual acetyl-
transferase activity, relative to wild type (Figures 21D and 21E). None of these substitutions
is able to deprotonate the substrate. However, if either of these two residues S812 and D813 is
retained, then either the hydroxyl group of serine or the carboxyl group of aspartate could act
as a general base. Hence, we transfected the double mutant MmEsco1S812A;D813A into MEF-
sEsco1-/-. This double mutant resulted in base-line level activity of MmEsco1 (Figures 21D and
21E) implying that both of S812 and D813 can perform deprotonation of the substrate lysines.
The residual activity of the MmEsco1D813A mutant argues that another general base could be
involved in the deprotonation of the substrate in case of D813 being incapacitated. A good
candidate is E728. However, the carboxyl group of this residue is nearly 10 Å away from the
carbonyl group of the acetylated CoA model structure (Figures 11A and 11B). Thus, direct
substrate lysine deprotonation by E728 is less likely and would require either water molecules
or polar residues as proton shuttle. S812 and S773 are well positioned to transfer the proton
from the substrate lysine ϵ-amino group to the E728 (Figure 11B). The MmEsco1E728Q mutant
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showed 40% residual activity relative to wild type suggesting that E728 could indeed play the
role of a general base if D813 is mutated. A double mutant of D813 and E728
(MmEsco1D813A;E728Q) was enzymatically inactive supporting the assumption that one of the
general bases, D813 or E728, can deprotonate the ϵ-amino group of substrate lysines.
MmEsco1S812A and MmEsco1S773A mutants still reached 30-40% of activity in acetylating
Smc3, relative to wild type. However, the double mutant MmEsco1S812A;S773A was completely
inactive. These findings suggest that either of these two serines can act as a proton shuttle.
Altogether, the most cautious interpretations of our data suggest that S812, D813, S773 and
E728 residues can redundantly cooperate in deprotonation. In case of a mutation they can re-
place each other in an in vivo complementation assay. In vitro, however, such substitution is
not seen.
Importantly, the catalytically inactive MmEsco1 mutants bound to the chromatin in the same
manner as reported for the endogenous MmEsco1 (Hou and Zou, 2005) (Figure 21B). This
would thus argue against an effect on protein mislocalization.
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Figure 21: S812, D813, S773, and E728 function cooperatively in the catalysis of MmEsco1.
(A) Flow cytometry profiles of G1-phase arrested MEFsEsco1-/- expressing wild type or mutant MmEsco1.
Unsynchronized MEFsEsco1-/- were used as controls. (B) Immunoblot analysis of MEFsEsco1-/- expressing
wild type and catalytically dead mutants of MmEsco1-myc. Wild type and mutants localize to chromatin.
S: soluble fraction, C: chromatin. (C) Establishment of an in vivo acetylation assay in MEFsEsco1-/-. The
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Smc3 acetylation level of chromatin-bound fractions was analyzed by Western blotting using an AcSmc3-
specific antibody. The lysate for each sample was loaded in three dilutions: 1X, 2X, and 4X.  Of note, transiently
transfected MmEsco1 was expressed at a level about 4 fold that of endogenous MmEsco1 (compare lanes 3 and
7). (D) Representative immunoblot of MEFsEsco1-/- transiently expressing wild type or mutant versions of
MmEsco1-myc, arrested in G0/G1-phase. The ability of the MmEsco1 mutants to acetylate Smc3 was assessed
by quantitative Western blotting using an AcSmc3-specific antibody. Chromatin-bound fractions were used.
Note that MEFsEsco1−/− expressed comparable levels of different MmEsco1-myc variants. The lysate for each
sample was loaded in three dilutions: 1X, 2X, and 4X. (E) Quantification of the data shown in (D). The dotted
line indicates the Smc3 acetylation value for MEFsEsco1-/-. Data were normalized to maximal signal and are
shown as mean ± SEM (n=3).
3.5.2 Effect of catalytic site mutants of MmEsco2 on Smc3 acetylation
The above in vivo complementation results were examined using mutant MmEsco2 versions,
transfected into Esco2-deficient MEFs.
Esco2 deficient MEFs (MEFsEsco2-/-) were generated by transduction of MEFsEsco2fl/fl with ade-
noviral Cre (AdCre). MEFsEsco2-/- were stably transfected with C-terminally myc-tagged
MmEsco2 and myc-tagged mutants MmEsco2S566A, MmEsco2D567A, MmEsco2D567N,
MmEsco2S527A, MmEsco2E491Q, MmEsco2S566A;D567A, and MmEsco2S527A;S566A (Figure 22B).
Synchronization of cells in S-phase showed that the mutant versions did not affect cell cycle
progression (Figure 22A). Cells deficient for Esco2 showed reduced Smc3 acetylation (Figure
22C). Residual Smc3 acetylation is most likely due to MmEsco1 that is expressed throughout
the cell cycle (Lafont et al., 2010; Whelan et al., 2012). Transfection of Esco2-deficient MEFs
with MmEsco2 but not with a MmEsco2D567N mutant construct and the two double mutant
constructs, MmEsco2S566A;D567A and MmEsco2S527A;S566A, restored Smc3 acetylation (Figures
22D and 22E). These results are in close agreement with the effect of the same mutants on
MmEsco1 activity. However, the effect of single mutations (S566A, D567A, S527A and
E491Q) on the degree of Smc3 acetylation was less pronounced than that observed for the
MmEsco1 isoform. For instance, MmEsco2S566A and MmEsco2S527A showed about 60-80%
residual acetyltransferase activity relative to wild type. In addition, MmEsco2D567A and
MmEsco2E492Q mutants acetylated Smc3 to the same extent as its wild type control (Figures
22D and 22E). This difference between Esco1 and Esco2 could be due to the fact that in vivo
Esco1 and Esco2 act in a different molecular context. For example, only Esco2 acetylates
Smc3 in the context of DNA replication (Hou and Zou, 2005; Ivanov et al., 2018).
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In summary, our in vivo mutant data propose that MmEsco2 and MmEsco1 function in differ-
ent contexts but show similarity in their catalytic mechanism. In agreement with MmEsco1,
MmEsco2 can engage alternative catalytic residues S566, D567, S527, and E491 that redun-
dantly act in deprotonation of substrate lysines.
Importantly, all MmEsco2 variants bound to the chromatin in the same manner as reported for
the endogenous MmEsco2 (Hou and Zou, 2005) (Figure 22B). This would thus argue against
an effect on protein mislocalization.
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Figure 22: S566, D567, S527, and E491 function cooperatively in the catalysis of MmEsco2.
(A) Flow cytometry profiles of S-phase arrested MEFsEsco2-/- expressing wild type or mutant MmEsco2. Un-
synchronized MEFsEsco2-/- were used as controls. (B) Immunoblot analysis of MEFsEsco2-/- expressing equiva-
lent amounts of ectopic MmEsco2-myc variants. Wild type and mutant MmEsco2-myc localize to chromatin. S:
soluble fraction, C: chromatin. Representative mutants are shown. (C) Establishment of an in vivo acetylation
assay in MEFsEsco2-/-. The Smc3 acetylation level of chromatin-bound fractions was analyzed by Western blotting
using an AcSmc3-specific antibody. The lysate for each sample was loaded in three dilutions: 1X, 2X, and 4X.
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(D) Representative immunoblot of MEFsEsco2-/- expressing wild type or mutant versions of MmEsco2-myc,
arrested in S-phase. The ability of the MmEsco2 mutants to acetylate Smc3 was assessed by quantitative West-
ern blotting using an AcSmc3-specific antibody. Chromatin-bound fractions were used. The lysate for each sam-
ple was loaded in three dilutions: 1X, 2X, and 4X. (E) Quantification of the data shown in (D). The dotted line
indicates the Smc3 acetylation value for MEFEsco2-/-. Data were normalized to signal of MEFsEsco2fl/fl and are
shown as mean ± SEM (n = 3).
Effect of catalytic site mutants of MmEsco2 on sister chromatid co-
hesion
A number of naturally occurring mutations in HsEsco2 cause Roberts syndrome (RBS), a
developmental disease in which prometaphase chromosomes have a railroad track appearance
(with separate centromeres and cohered arms). Most of these mutations lead to nonsense-
mediated decay or affect the catalytic domain of the enzyme (Ivanov et al., 2002; Rivera-
Colon et al., 2016). Therefore, loss of HsESCO2 acetyltransferase activity is believed to cause
loss of cohesion in RBS patients. Esco2-deficiency in MEFs recapitulates the defect seen in
RBS in mouse prometaphase chromosomes (Figure 23A) (Whelan et al., 2012). Therefore, to
confirm the functional importance of the catalytic mutants of MmEsco2 and to complement
the in vivo Smc3 acetylation analysis above (see 3.5), we investigated the effect of these mu-
tants on sister chromatid cohesion.
MEFsEsco2-/- were transfected with wild type or different mutant versions of MmEsco2. Cells
were synchronized in prometaphase, isolated by mitotic shake-off, and used for chromosome
spread preparation. Consistent with the results from the Smc3 acetylation rescue experiments
(Figures 22D and 22E), chromosome morphology analysis revealed that MmEsco2D567N,
MmEsco2S566A;D567A and MmEsco2S527A;S566A do not rescue the sister chromatid cohesion de-
fect (Figure 23B). However, single mutants MmEsco2S566A, MmEsco2D567A, MmEsco2S527A,
and MmEsco2E491Q that still showed intrinsic acetyltransferase activity (Figures 22D and 22E)
also restored wild type appearance of cohesion at least  to some extent (Figure 23B). These
observations are in close agreement with the effect of MmEsco2 catalytic mutants on Smc3
acetylation and hence support the notion of a redundant function of S566, D567, S527, and
E491 in the catalytic activity of MmEsco2.
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Another phenotype that is related to sister chromatid cohesion is Aurora B localization on the
chromosomes (Whelan et al., 2012; Carretero et al., 2013). Localization of Aurora B on cen-
tromeres is essential for centromeric cohesion through recruitment of Shugoshin 1 (Sgo1)
(Kelly et al., 2010, Wang et al., 2010, Wang et al., 2011, De Antoni et al., 2012). It has been
shown that Esco2-deficiency leads to relocalization of Aurora B from centromeres to the arms
of prometaphase chromosomes (Figure 24A) (Whelan et al., 2012). To further confirm the
functional importance of the catalytic MmEsco2 mutants, we studied the effect of two catalyt-
ic mutations of MmEsco2, D567A and D567N, on localization of Aurora B on mitotic chro-
mosomes. MmEsco2D567A is representative of mutants with no effect on enzyme activity and
MmEsco2D567N is one of the catalytic mutants that abolish the enzyme activity. Aurora B im-
munostaining of prometaphase chromosomes was done in MEFsEsco2-/- transfected with wild
type or the two different mutant versions. The results showed a relocalization of Aurora B
immunoreactivity from centromeres to the arms for the MmEsco2D567N mutant but not the
MmEsco2D567A mutant (Figures 24A and 24B). Thus, the acetyltransferase-deficient
MmEsco2D567N mutant cannot restore the proper localization of Aurora B in Esco2-deficient
cells. These observations confirm the involvement of the employed catalytic candidate resi-
due, D567, in the catalytic activity of MmEsco2.
In summary, these findings in addition to other in vivo assays suggest that MmEsco2 uses at
least four residues in the active site including S566, D567, S527, and E491 that cooperatively
involve in the catalytic activity of the enzyme.
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Figure 23: Sister chromatid cohesion is dependent on the acetyltransferase activity of Esco2.
(A) Representative prometaphase chromosomes spreads including normal, railroad and single chromatids.
Scale bar: 10 µm (B) Frequency of chromosome types were assessed in 1000 prometaphase chromosomes per
MmEsco2 mutant.
Figure 24: Aurora B localization is dependent on the acetyltransferase activity of MmEsco2.
(A) Representative immunoreactivity staining of Aurora B in prometaphase chromosomes spreads showing
centromere localization or centromere-arms localization. Nuclei were counterstained with DAPI. Scale bar: 10
µm (B) Frequency of prometaphase chromosomes with Aurora B enrichment at the centromeres or centromeres
and arms for D567 Esco2 mutants. 1000 prometaphase chromosomes per MmEsco2 mutant were assessed.
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Discussion
The architecture of MmEsco2 in complex with CoA
We determined the structure of the MmEsco2368-592 acetyltransferase domain natively com-
plexed with CoA. It contains a mixed α-helix and β-sheet structure forming a globular fold
that is structurally conserved among all GNAT family members (Figure 10A). CoA is wedged
into a groove consisting of two central β-strands (β7 and 8) and two α-helices (α3 and 4)
(Figure 10A). The presence of CoA is likely required to stabilize the overall folding of the
MmEsco2 acetyltransferase domain, as has previously been suggested for other acetyltrans-
ferases (Friedmann and Marmorstein, 2013). Our structure is from recombinant protein con-
taining CoA but not AcCoA. Attempts to substitute CoA by AcCoA in the crystal were not
successful. However, other Esco acetyltransferase domain crystal structures contain AcCoA
and thus the position of the acetyl moiety can be modeled into the MmEsco2368-592 acetyl-
transferase domain.
A structural similarity search against available structures in the Protein Data Bank (PDB) us-
ing DALI (Holm and Rosenstrom, 2010) or SSM (Krissinel and Henrick, 2004) revealed that
acetyltransferase domain of MmEsco2 shows structural similarities to other GNAT family
members (xEco2, HsESCO1, HsαTAT1, HsGCN5) as well as to the acetyltransferase domain
of the MYST family member ScEsa1 (Table 4). Table 4 shows that the xEco2 folds have the
highest Z-scores and lowest RMSD compared with other Esco orthologs. A conserved C-
terminal extension and an extended β-hairpin between two β-strands in xEco2-K105-CoA
mediate specific binding of the substrate (Chao et al., 2017). The corresponding regions in
MmEsco2 are structurally conserved suggesting the same regions would be involved in sub-
strate binding (Figure 25). It should be noted that in MmEsco2 and xEco2, part of the extend-
ed β-hairpin (S501-C515 of MmEsco2) (L609-W623 of xEco2) is unresolved suggesting
structural flexibility that might enable interaction with subunits of the cohesin ring or cohesin
regulators.
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Table 4: Structural similarity search using SSM.
 * RMSD: root-mean-square deviation
Proteins(accession
numbers)
RMSD
(Å)
length of
alignment
Identity
(%)
Z-score
xEco2 (5N1W) 0.78 152 68 15.7
xEco2 (5N1U) 0.92 154 68 14.6
HsESCO1 (4mxe) 1.13 155 58 12.9
HsESCO1 (5T53) 1.58 152 58 10.7
HsαTAT1 (4PK2) 2.23 125 10 8.2
ScEsa1 (1MJB) 2.46 126 10 6.9
HsGcn5 (1Z4R) 2.65 120 11 7.9
*
xEco2
K105-CoA peptide
MmEsco2
CoA
C extension
β hairpin
S501
C515
L609
W623
Figure 25: Superposition of MmEsco2/CoA with xEco2/K105-CoA.
Alignment of MmEsco2/CoA (green) and the xEco2/K105-CoA peptide (blue; PDB ID code 5N1W). The
Smc3 peptide K105 is shown in raspberry. The functionally important β hairpin and C-terminal extension of
MmEsco2 are labeled. Note that one part of the β hairpin is unresolved (shown with dashed lines) in the
acetyltransferase domain of MmEsco2 and xEco2.
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Characterization of the active site of Esco1 and Esco2
The active site of MmEsco2368-592 (Figure 11A) is readily identified by the location of the co-
factor coenzyme A. Based on the interatomic distances, four potential catalytic residues could
be identified (S566, D567, S527 and E491) (Figures 11A and 11B). To explore whether these
residues contribute to catalysis, we developed in vitro acetyltransferase assays as well as cell-
based assays that detect cohesin acetylation in vivo. For in vitro assays, we used recombinant
HsESCO1, since we failed to produce sufficient amounts of either mouse or human recombi-
nant Esco2.
4.2.1 In vitro cohesin acetylation requires ATP hydrolysis and DNA
So far, only autoacetylation of Esco1 and Esco2 and Smc3 peptide acetylation by Esco1 have
been shown. These are slow reactions and thus may not properly recapitulate in vivo activity
of Esco enzymes. The sole exception to this was Peters’s lab work, that has used trimeric co-
hesin without nucleic acid (Ladurner et al., 2014). To better model the true substrate, we used
tetrameric cohesin complex. We found that full-length HsESCO1 can acetylate SMC3 in vitro
in the presence of both ATP and DNA. The requirement for DNA is consistent with the fact
that in vivo only chromatin bound cohesin is acetylated (Morales and Losada, 2018). Moreo-
ver, requirement for ATP is consistent with the finding that cohesin loading onto chromatin
and subsequent cohesin acetylation depends on ATP hydrolysis mediated by the SMC3 head
domain (Camdere et al., 2015; Ladurner et al., 2014; Murayama and Uhlmann, 2014).
Of note, we found that addition of DNA and/or ATP did not enhance HsESCO1 autoacetyla-
tion. Therefore, the physiological function of nucleic acids and ATP has to be viewed in the
context of Esco proteins acetylating the cohesin ring.
4.2.2 In vitro analysis of active site mutants of HsESCO1
The active site model shown in Figure 11A and 11B implicates S566 and D567 as potential
catalytic residues in MmEsco2368-592. Accordingly, equivalent serine and aspartic acid resi-
dues in HsESCO1 (see Figure 11D) were mutated as follows: S809A, S809C, D810A, and
D810N. All mutants were catalytically inactive in the in vitro assay. In agreement with these
results, an in vitro mutagenesis study of recombinant HsESCO1590–840 with a 21 amino acid
long SMC3 peptide as substrate also showed that S809A and D810N mutations are catalyti-
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cally inactive (Rivera-Colon et al., 2016). This suggests that both S809 and D810 (S566 and
D567 of MmEsco2) are involved in catalysis. The position of D810 in the structure of xEco2
complexed with a K105-CoA-Smc3 peptide is such that it could act as a general base to
deprotonate the ε-group of the K105 (Figure 12A). Chao (2017) also noted the presence of a
salt bridge between D810 and K106 of the Smc3 peptide. Hence, it is possible that D810 is
involved in an enzyme-substrate interaction and additionally abstracts a proton from K105.
We propose that there could be a proton transfer from K105 to D810 that involves S809 as a
proton shuttle. Once K105 is acetylated, CoA dissociates and a new cofactor is bound to Apo
Esco. As a next step, the holoenzyme now acetylates K106. Because D810 is no longer
properly positioned for salt bridge formation, it could act either directly as the general base or
S809 again acts as a proton shuttle. This model would explain why S809A, S809C, D810A,
and D810N mutations are all catalytically inactive.
4.2.3 In vivo analysis of active site mutants of MmEsco1
Are the above active site mutants catalytically inactive in vivo? Transfecting different
MmEsco1 mutants into Esco1-deficient MEFs and assessing Smc3 acetylation showed that all
mutants except for D813N had surprisingly still partial activity. All mutants used in our work
have been shown to be properly folded based on their gel filtration elution profiles (Rivera-
Colon et al., 2016). The full loss of activity of the D813N mutant despite the residual activity
of the D813A mutant enzyme support the view that D813 is not only involved in catalysis but
also in substrate binding (see above). Engagement of an active site residue in both catalysis
and substrate binding has also been found for the HsαTAT1 acetyltransferase (Szyk et al.,
2014). D157 of HsαTAT1 acts as a general base in catalysis and interacts with the substrate
lysine (Szyk et al., 2014). D157 is located in the equivalent position as D813 MmEsco1 and
D567 in MmEsco2 (Figure 14). Reminiscent of MmEsco1, a D157N mutation in HsαTAT1
resulted in a complete loss of acetyltransferase activity (Taschner et al., 2012).
Why are S812A/C and D813A partially active in vivo? As pointed out above, β-strands 6 and
7 project side chains of E728 and S773 into the active site. These residues could act as a gen-
eral base and proton shuttle, respectively. Single mutations of residues S773A and E728Q did
not abrogate the catalytic activity of MmEsco1. However, mutations of both general bases
(E728Q;D813A) led to a complete loss of enzymatic activity. This suggests that either D813
or E728 can deprotonate substrate lysines. We have argued above that S812 acts as a proton
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shuttle and S773 could do the same. This possibility is supported by the absence of any enzy-
matic activity in S812A;S773A MmEsco1 double mutant. The role of serine as proton shuttle
in substrate deprotonation was also proposed for the Dat acetyltransferase, which employs a
glutamate residue to deprotonate the amino group of the substrate through a serine residue
(Cheng et al., 2012).
It is possible that S773, S812, D813 and E728 play a redundant role in deprotonation of the
substrate even in the native enzyme. However, it is also possible that the catalytic activity of
E728 and S773 comes to the fore only in the absence of S812 and D813. An equivalence of
the two pairs would require similar rates of catalysis mediated by either pair of residues. Cur-
rently these rates are unknown. However, in our in vivo context, we observed that extend of
Smc3 acetylation is very similar in either E728 and S773 or S812 and D813 mutations.
In vitro, human ESCO1 mutations S809A, S809C, D810A and D810N are inactive. Interest-
ingly, we found that the mouse ortholog residues mutations (S812A, S812C and D813A)
showed up to 50% of wild type activity in vivo. The other single MmEsco1 mutants, S773A
and E728Q, with partial catalytic activity in our in vivo assays are also catalytically inactive in
vitro (Rivera-Colon et al., 2016). Why is that? It is known that cohesin regulators Pds5A,
Pds5B, MCM and chromatin are required for Smc3 acetylation in cells (Carretero et al., 2013;
Ivanov et al., 2018; Minamino et al., 2015). Therefore, we speculate that presence of one or
several of these factors enhance Esco activity. This limitation makes the point that an in vivo
assessment of various Esco mutant activity is crucial for understanding catalysis.
4.2.1 In vivo analysis of active site mutants of MmEsco2
The results from the in vivo mutational studies for MmEsco2 using both Smc3 acetylation and
sister chromatid cohesion as readouts are consistent. Thus, mutations impairing Smc3 acetyla-
tion also cause sister chromatid cohesion defects. Furthermore, identical mutations in either
MmEsco1 or MmEsco2 evoke Smc3 acetylation deficiencies to a similar qualitative extent
(Figures 21E and 22E). Nonetheless, there are some quantitative differences. An example for
such a quantitative difference is the effect of the single mutation D813A in MmEsco1 (corre-
sponding to D567A in MmEsco2). While the extent of Smc3 acetylation is reduced by 50% in
the MmEsco1 mutant, wild type levels are retained in the MmEsco2 mutant. This difference
between Esco1 and Esco2 could be due to the fact that they act in a very different molecular
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context in vivo. Esco1 directly acetylates Smc3 while bound to chromatin. In contrast, Esco2
acetylates cohesin only in the context of a DNA replication fork (Hou and Zou, 2005; Ivanov
et al., 2018).
Taken together, we proposed that the general base in either Esco1 or Esco2 abstracts the sub-
strate proton via a serine residue (Figure 26). This hypothetical mechanism is based on the
crystallographic evidence along with site-directed mutagenesis performed in this study as well
as in recent reports from other laboratories (Chao et al., 2017b; Rivera-Colon et al., 2016). In
the case of mutagenesis of D567 or S566, active site residues E491 and S527 can compensate.
In a way, the active sites of Esco1 and Esco2 are mirror symmetrical. Esco1 and Esco2 se-
quentially acetylate two distinct lysine residues located next to each other on Smc3. It is pos-
sible that the dual active reflects this task.
Figure 26: Proposed catalytic mechanism for Esco1 and Esco2.
(A) The proposed mechanism involves D566, acting as a general base, to initiate the reaction by abstracting a
proton from the hydroxyl group of S566. Subsequently, the hydroxylate of S566 can then act as base catalyst
to deprotonate the amino group of K105 and /or K106. This is followed by the nucleophilic attack of the amine
on the carbonyl carbon of AcCoA. Blue arrows indicate deprotonation and red arrows the nucleophilic attack.
The numbering of putative catalytic residues is based on the MmEsco2 sequence (Figure 11D). (B) In the case
of mutagenesis of the D567 active site residue, E491 using S527 as a proton shuttle compensate.
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Structural interpretation of Roberts syndrome mutations
The structure of MmEsco2368-592 provides an interpretation of the Roberts-syndrome-
associated mutations (Vega et al., 2010). In Roberts syndrome most mutations lead to stop
codons in the amino terminal domain that are not present in the MmEsco2368-592 structure.
However, W539G, G581R, and deletion of E453 are in the catalytic domain. Human W539
(W530 in MmEsco2), which resides on the β7-strand, is part of a hydrophobic core (Figure
27) that might stabilize the AcCoA binding fold and α2-helix (Figure 27). Our xEco2-Smc3
docking study suggests that the α2 helix could represent an important domain for substrate
binding (Figure 28). Therefore, mutation of W539 might indirectly interfere with the substrate
binding. In addition, it could also disturb the AcCoA binding and hence, indirectly reduce the
enzyme stability. This idea is supported by the finding that an equivalent mutation in
HsESCO1 (W773G) leads to a dramatic reduction in thermal stability of the mutant protein
and possibly substrate binding (Rivera-Colon et al., 2016). E453 is located in the middle of
the α2-helix (Figure 27), a potential region for substrate binding (see above). Removing E453
from the helix could results in a ~120° reorientation of the side chains of adjacent C-
terminally positioned residues. Thus, there is a rotation that puts hydrophobic residues of α2
towards the protein surface and hydrophilic residues towards the inside of the catalytic do-
main, which subsequently could impair substrate binding. G581 (G572 in MmEsco2) is locat-
ed in the α4-helix and is in close proximity to CoA (Figure 27). This implies that a G to R
mutation may sterically obstruct the entry of AcCoA into the active site.
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Figure 27: Disease-associated Esco2 mutations.
Esco2 residues that are mutated in Roberts Syndrome are underlined. Adjacent interacting residues are labeled.
The numbering of putative catalytic residues is based on the MmEsco2 sequence.
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Figure 28: Substrate binding sites of Esco acetyltransferases.
Stereo view of the docking of the xEco2-K105-CoA structure (xEco2 in blue and Smc3 peptide in salmon)
onto the S. cerevisiae Smc3 (gray; PDB ID 4UX3) structure based on the positions of the K105 and K106 (S.
cerevisiae K112 and K113) residues. Potential substrate binding regions, α2 helix, β hairpin and C extension
are labeled.
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Additional Data
MmEsco2368-592 shows inefficient autoacetyltransferase activity
To investigate the contribution of the potential catalytic residues, a thorough characterization
of the corresponding mutants is essential. To do this, we first tried to establish an in vitro
acetylation assay using MmEsco2368-592 and different lengths of the Smc3 peptides (14, 24 and
29 residues). The results showed that MmEsco2368-592 could not acetylate the Smc3 peptides,
at least under our in vitro conditions (Figure 29A). However similar to previous reports, the
enzyme showed autoacetylation with a very slow rate (Gordillo et al., 2008) (Figures 29A and
29C). After establishment of the in vitro autoacetylation assay, the acetyltransferase activity
of different MmEsco2368-592 mutants (S566A, S566C, D567A and D567Q) was assessed and
compared to wild type MmEsco2368-592. Unexpectedly, all mutants showed some degree of
autoacetylation activity (Figure 29D). This was in contrast to the strong structural evidence
for engagement of the two adjacent residues, S566 and D567, in catalysis. Since,
MmEsco2368-592 autoacetylation was highly inefficient (saturation took more than 12 hours)
(Figure 29C), we assume that some part of autoacetylation activity may result from non-
enzymatic activity.
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HsESCO2 does not acetylate the trimer under in vitro conditions
We could not purify sufficient amount of recombinant HsESCO2 for all in vitro assays. How-
ever, it was enough to assess the activity of this enzyme using a limited number of acetylation
assays. MBP-tagged HsESCO2 was incubated with trimeric cohesin in the presence of ATP,
DNA and AcCoA. The results showed that HsESCO2 does not acetylate the trimer, although
an equal amount of HsESCO1 acetylates the trimer under the same in vitro conditions (Figure
30). One explanation for these results could be that HsESCO2 requires the presence of addi-
tional factors for cohesin acetylation. However, we do not rule out the possibility that the lack
of enzymatic activity of HsESCO2 might be due to MBP fusion. Limitations in production of
recombinant HsESCO2 did not allow us to study this issue further.
Figure 29: MmEsco2368-592 shows inefficient autoacetyltransferase activity.
(A) MmEsco2368-592 does not acetylate the Smc3 peptide. The Smc3 peptide (29 residues; 4.8 kDa) was incu-
bated with purified MmEsco2368-592 (28kD) and [14C] AcCoA. Acetylation was analyzed by SDS-PAGE fol-
lowed by Coomassie blue staining and phosphorimaging. (B) MmEsco2368-592 shows autoacetylation activity.
MmEsco2368-592 (28kD) was incubated with or without [14C] AcCoA and acetylation activity was assessed as
in (A). (C) Autoacetylation activity of MmEsco2368-592 is inefficient. Purified MmEsco2368-592 was incubated
with [14C] AcCoA for different amounts of time. Acetylation activity was assessed as in (A) and normalized to
time point t=0 hr. (D) The effect of MmEsco2368-592 mutants on autoacetylation activity was assessed by SDS-
PAGE followed by silver staining and phosphorimaging.
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In vitro cohesin acetylation shows salt sensitivity
Our results implicated the need of topological loading of cohesin on DNA for SMC3 acetyla-
tion. It has been shown that cohesin topological loading onto DNA requires low salt concen-
trations under in vitro condition. Therefore, we speculated that the rate of SMC3 acetylation
might increase by reducing the salt concentration in our in vitro conditions to allow more effi-
cient loading of cohesin onto DNA. To test this assumption, first trimeric cohesin complex,
ATP and DNA were incubated in the presence of low and high concentrations of NaCl for 1
hour (first incubation). To initiate the acetylation process, HsESCO1 was added to the reac-
tions and concentrations of NaCl were adjusted (second incubation). Interestingly, the results
revealed that efficient SMC3 acetylation by HsESCO1 required an initial incubation of cohe-
sin together with ATP and DNA in low salt conditions, probably to allow cohesin loading
onto DNA (Figure 31). However, the acetylation process by HsESCO1 required a higher con-
centration of NaCl to be more efficient. These findings support our previous observation, that
topological loading of cohesin onto DNA is required for cohesin acetylation.
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Figure 30: HsESCO2 does not acetylate the trimer under in vitro conditions.
Purified trimeric cohesin complex was incubated with increasing concentrations of HsESCO2 in the presence
of AcCoA, ATP and DNA. HsESCO1 was used as a positive control. Note that the structures of the catalytic
domains of ESCO1 and ESCO2 are highly conserved (Figure 13). SMC3 acetylation levels were analyzed by
Western blotting using a AcSmc3-specific antibody.
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S809 and D810 are crucial for the autoacetylation activity of
HsESCO1 under in vitro conditions
HsESCO1 showed autoacetyltransferase activity independent of DNA and ATP under in vitro
conditions (Figure 32A). Therefore, we quantified the autoacetylation of wild type and mutant
versions of ESCO1 by Western blotting using an pan-acetyl antibody. In regard to the in vitro
SMC3 acetylation results, autoacetylation of all tested mutants was markedly reduced (Fig-
ures 32B and 32C).
These results show that both S809 and D810 are required for the catalytic activity of the en-
zyme. However, superposition of MmEsco2/CoA and xEco2/K105-CoA suggests that S809
and D810 are also well positioned to play a role in substrate recognition and binding (Figure
12A).
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Figure 31: Salt sensitivity of cohesin acetylation in vitro.
The first incubation containing trimeric cohesin complex, ATP, AcCoA and DNA was carried out in the pres-
ence of the indicated concentrations of NaCl for 1 hour (first incubation). To initiate the acetylation process,
HsESCO1 was added to the reactions in the presence of the indicated concentrations of NaCl (second incuba-
tion). SMC3 acetylation was analyzed by Western blotting using an AcSmc3 specific antibody.
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Figure 32: S809 and D810 are crucial for the autoacetylation activity of HsESCO1 under in vitro
condition.
(A) ATP and DNA do not affect the autoacetylation activity of HsESCO1. Purified HsESCO1 was incubated
with AcCoA in the presence or absence of ATP and DNA. The level of HsESCO1 autoacetylation was ana-
lyzed by Western blotting using an anti-pan-Aacetyl antibody. (B) and (C) Time course quantification of the
outoacetylation activity of wild type and putative active site mutants of HsESCO1. Relative intensity of
HsESCO1 autoacetylation was quantified as in (A). Data were normalized to the maximal signal and are shown
as mean ± SEM (n=2).
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